JPH10274829A - Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the same - Google Patents
Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the sameInfo
- Publication number
- JPH10274829A JPH10274829A JP8045797A JP8045797A JPH10274829A JP H10274829 A JPH10274829 A JP H10274829A JP 8045797 A JP8045797 A JP 8045797A JP 8045797 A JP8045797 A JP 8045797A JP H10274829 A JPH10274829 A JP H10274829A
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- solid processing
- processing agent
- silver halide
- sensitive material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 101
- 238000012545 processing Methods 0.000 title claims abstract description 97
- 239000007787 solid Substances 0.000 title claims abstract description 67
- 239000000463 material Substances 0.000 title claims description 46
- -1 silver halide Chemical class 0.000 title claims description 38
- 229910052709 silver Inorganic materials 0.000 title claims description 23
- 239000004332 silver Substances 0.000 title claims description 23
- 238000000034 method Methods 0.000 title claims description 18
- 239000003826 tablet Substances 0.000 claims abstract description 193
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 6
- 239000007932 molded tablet Substances 0.000 claims abstract description 5
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 150000001768 cations Chemical class 0.000 claims abstract description 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 238000009459 flexible packaging Methods 0.000 claims description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 33
- 239000000203 mixture Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000007906 compression Methods 0.000 description 13
- 230000006835 compression Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 12
- 238000005469 granulation Methods 0.000 description 11
- 230000003179 granulation Effects 0.000 description 11
- 239000000758 substrate Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 9
- 238000000748 compression moulding Methods 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 239000005022 packaging material Substances 0.000 description 5
- 239000000123 paper Substances 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000004848 polyfunctional curative Substances 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 2
- LAQYHRQFABOIFD-UHFFFAOYSA-N 2-methoxyhydroquinone Chemical compound COC1=CC(O)=CC=C1O LAQYHRQFABOIFD-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000011124 aluminium ammonium sulphate Nutrition 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 description 2
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000005021 flexible packaging material Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 150000002892 organic cations Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 150000003455 sulfinic acids Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000003232 water-soluble binding agent Substances 0.000 description 2
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SVJPLZNMCJQWPJ-UHFFFAOYSA-N 1-(4-methylphenyl)pyrazolidin-3-one Chemical compound C1=CC(C)=CC=C1N1NC(=O)CC1 SVJPLZNMCJQWPJ-UHFFFAOYSA-N 0.000 description 1
- CCKNPKNHNFDGND-UHFFFAOYSA-N 1-fluoro-3-(isothiocyanatomethyl)benzene Chemical compound FC1=CC=CC(CN=C=S)=C1 CCKNPKNHNFDGND-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- XZZWGQJWQDJJBX-UHFFFAOYSA-N 2-(4-amino-3-methylphenyl)-1,3-dihydropyrazol-5-amine Chemical compound C1=C(N)C(C)=CC(N2NC(N)=CC2)=C1 XZZWGQJWQDJJBX-UHFFFAOYSA-N 0.000 description 1
- JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- CMZYMAFXGOVIHW-UHFFFAOYSA-N 2-[4-(methylamino)phenyl]-1,3-dihydropyrazol-5-amine Chemical compound C1=CC(NC)=CC=C1N1NC(N)=CC1 CMZYMAFXGOVIHW-UHFFFAOYSA-N 0.000 description 1
- XWKAZXKJYHZGAI-UHFFFAOYSA-N 2-acetyl-4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound C1C(C)(C)C(=O)N(C(=O)C)N1C1=CC=CC=C1 XWKAZXKJYHZGAI-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FBTQPCXUTWYBDX-UHFFFAOYSA-N 4-(5-amino-1,3-dihydropyrazol-2-yl)phenol Chemical compound N1C(N)=CCN1C1=CC=C(O)C=C1 FBTQPCXUTWYBDX-UHFFFAOYSA-N 0.000 description 1
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 description 1
- XSFKCGABINPZRK-UHFFFAOYSA-N 4-aminopyrazol-3-one Chemical compound NC1=CN=NC1=O XSFKCGABINPZRK-UHFFFAOYSA-N 0.000 description 1
- FQQGQVUWBXURTA-UHFFFAOYSA-N 4-ethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CC)CN1C1=CC=CC=C1 FQQGQVUWBXURTA-UHFFFAOYSA-N 0.000 description 1
- ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)CN1C1=CC=CC=C1 ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 0.000 description 1
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 1
- FIARATPVIIDWJT-UHFFFAOYSA-N 5-methyl-1-phenylpyrazolidin-3-one Chemical compound CC1CC(=O)NN1C1=CC=CC=C1 FIARATPVIIDWJT-UHFFFAOYSA-N 0.000 description 1
- NTJPVVKEZMOHNU-UHFFFAOYSA-N 6-(oxan-4-yl)-1h-indazole Chemical compound C1COCCC1C1=CC=C(C=NN2)C2=C1 NTJPVVKEZMOHNU-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000001715 Ammonium malate Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- GQUZTSGWULGOLE-UHFFFAOYSA-N C(C)(=O)O[C-]1NN(CC1=O)C1=CC=CC=C1 Chemical compound C(C)(=O)O[C-]1NN(CC1=O)C1=CC=CC=C1 GQUZTSGWULGOLE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- WTBIAPVQQBCLFP-UHFFFAOYSA-N N.N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O Chemical compound N.N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTBIAPVQQBCLFP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- KGECWXXIGSTYSQ-UHFFFAOYSA-N ammonium malate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)CC([O-])=O KGECWXXIGSTYSQ-UHFFFAOYSA-N 0.000 description 1
- 235000019292 ammonium malate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- NHJPVZLSLOHJDM-UHFFFAOYSA-N azane;butanedioic acid Chemical compound [NH4+].[NH4+].[O-]C(=O)CCC([O-])=O NHJPVZLSLOHJDM-UHFFFAOYSA-N 0.000 description 1
- SOJZPUFVOCGQIP-UHFFFAOYSA-M azanium;potassium;2,3-dihydroxybutanedioate Chemical compound [NH4+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O SOJZPUFVOCGQIP-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- LFHXPRTYXDXTDD-UHFFFAOYSA-H bis(2,2-dioxo-1,3,2,4-dioxathialumetan-4-yl) sulfate octahydrate Chemical compound O.O.O.O.O.O.O.O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LFHXPRTYXDXTDD-UHFFFAOYSA-H 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 235000019981 calcium hexametaphosphate Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- YDIQKOIXOOOXQQ-UHFFFAOYSA-H dialuminum;trisulfite Chemical compound [Al+3].[Al+3].[O-]S([O-])=O.[O-]S([O-])=O.[O-]S([O-])=O YDIQKOIXOOOXQQ-UHFFFAOYSA-H 0.000 description 1
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000011361 granulated particle Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000002651 laminated plastic film Substances 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- ZPPPLBXXTCVBNC-UHFFFAOYSA-M lithium;2,3-dihydroxybutanedioate;hydron Chemical compound [H+].[Li+].[O-]C(=O)C(O)C(O)C([O-])=O ZPPPLBXXTCVBNC-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000016337 monopotassium tartrate Nutrition 0.000 description 1
- 235000019321 monosodium tartrate Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229940081543 potassium bitartrate Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- VKDSBABHIXQFKH-UHFFFAOYSA-M potassium;4-hydroxy-3-sulfophenolate Chemical compound [K+].OC1=CC=C(O)C(S([O-])(=O)=O)=C1 VKDSBABHIXQFKH-UHFFFAOYSA-M 0.000 description 1
- PEFYPPIJKJOXDY-UHFFFAOYSA-J potassium;tetrachloroalumanuide Chemical compound [Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[K+] PEFYPPIJKJOXDY-UHFFFAOYSA-J 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 229940119126 sodium bitartrate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 239000001476 sodium potassium tartrate Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- KICVIQZBYBXLQD-UHFFFAOYSA-M sodium;2,5-dihydroxybenzenesulfonate Chemical compound [Na+].OC1=CC=C(O)C(S([O-])(=O)=O)=C1 KICVIQZBYBXLQD-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- KRSIWAJXDVVKLZ-UHFFFAOYSA-H tricalcium;2,4,6,8,10,12-hexaoxido-1,3,5,7,9,11-hexaoxa-2$l^{5},4$l^{5},6$l^{5},8$l^{5},10$l^{5},12$l^{5}-hexaphosphacyclododecane 2,4,6,8,10,12-hexaoxide Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)O1 KRSIWAJXDVVKLZ-UHFFFAOYSA-H 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Photographic Developing Apparatuses (AREA)
Abstract
Description
【0001】[0001]
【発明発明の属する技術分野】本発明はハロゲン化銀写
真感光材料(以下、感光材料ともいう)用固体処理剤に
関し、特に安定性に優れ、感光材料用自動現像機で用い
るのに適した固体処理剤、ハロゲン化銀写真感光材料用
固体処理剤の包装体及び投入方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a solid processing agent for a silver halide photographic light-sensitive material (hereinafter also referred to as a "light-sensitive material"), and particularly to a solid which has excellent stability and is suitable for use in an automatic developing machine for a photographic material. The present invention relates to a processing agent, a package of a solid processing agent for a silver halide photographic light-sensitive material, and a charging method.
【0002】[0002]
【従来の技術】感光材料用処理剤は濃縮液キットとして
供給され、使用時に希釈調液する方法が主となってい
る。濃縮液キットは溶解性を懸念することなく調液時間
が短く、さらに、原料が溶液形態のものを使用できるた
め低コストで供給できる等の利点がある。一方、濃縮液
であることから皮膚に付着、特に眼に混入した場合等、
危険性が高く安全性に問題があった。更に、容器には頑
丈なプラスチックボトルを用いなければならず重量が重
く体積も大きくなることから輸送コストへの負荷が大き
くなっているばかりでなく、環境保護の点でも改善が求
められている。2. Description of the Related Art A processing agent for a photosensitive material is supplied as a concentrated solution kit, and a method of diluting and adjusting the solution at the time of use is mainly used. The concentrated solution kit has the advantages that the solution preparation time is short without concern about the solubility and that the raw material can be used in the form of a solution so that it can be supplied at low cost. On the other hand, because it is a concentrated solution, it adheres to the skin, especially when it gets into the eyes,
High risk and safety issues. Further, since a strong plastic bottle must be used for the container, the weight is large and the volume is large, so that not only the load on the transportation cost is increased, but also the improvement in environmental protection is required.
【0003】このため安全性、小型軽量、コンパクト性
の観点から処理剤の固体化が見直され、粉剤形態や錠剤
形態の処理剤が供給されてきている。ただし、粉剤形態
の場合は溶解時に粉塵が舞う等、溶解作業者が粉塵を吸
い込む危険性を有していた。Therefore, solidification of processing agents has been reviewed from the viewpoints of safety, small size, light weight and compactness, and processing agents in powder form and tablet form have been supplied. However, in the case of the powder form, there is a risk that the dissolving worker may inhale the dust, for example, when the dust flies when dissolving.
【0004】また更に、処理剤の保存安定性向上のため
に相互作用を及ぼす成分を各パートに分け保存し供給す
ることが知られており、異なる包装材料で包装して供給
する場合がある。したがって、各パートごとに供給する
方法は使用時のハンドリング性、誤溶解、自動溶解装置
での溶解等の観点から好ましくない。Further, it is known that components that interact with each other are stored and supplied in different parts in order to improve the storage stability of the processing agent. In some cases, the components are supplied after being packaged in different packaging materials. Therefore, the method of supplying each part is not preferable from the viewpoint of handling properties during use, misdissolution, dissolution by an automatic dissolution apparatus, and the like.
【0005】自動現像機による迅速処理が一般化してい
る一方で、固体処理剤の溶解装置を付与した自動現像機
も供給され、固体処理剤の溶解性の向上が望まれてい
る。更に固体処理剤の溶解漕への投入方法も自動化が望
まれるなかで包装材料からの良好な脱離性も要求されて
いる。[0005] While rapid processing by automatic developing machines has become common, automatic developing machines provided with a dissolving device for solid processing agents have also been supplied, and it has been desired to improve the solubility of solid processing agents. In addition, while the method of charging the solid processing agent into the dissolution tank is also desired to be automated, good detachability from the packaging material is also required.
【0006】圧縮成形により錠剤状にされている固体処
理剤(即ち錠剤)は、圧縮成形後臼内より放出される際
に錠剤上面のエッジ部に沿って錠剤に破断面が形成さ
れ、この破断面上側より帽子状に剥離するキャッピング
と呼ばれる故障が発生することが知られている。更に錠
剤上面が凸曲面を有する錠剤はキャッピング故障が発生
しやすいことが知られている。キャッピング故障は錠剤
の製造が困難になるだけでなく圧縮成型の際にキャッピ
ング故障が生じなくとも破断面が形成されているだけで
錠剤の硬度低下等の安定性、更には保存性を大きく劣化
させるため大きな問題であった。[0006] When the solid processing agent (ie, tablet) formed into a tablet by compression molding is released from the die after compression molding, a broken surface is formed in the tablet along the edge portion of the tablet upper surface, and the broken surface is formed. It is known that a failure called capping, which peels off in a hat shape from the upper side of the cross section, occurs. Furthermore, it is known that a tablet having a convex upper surface has a capping failure easily. Capping failure not only makes tablet production difficult, but also reduces the hardness of the tablet, etc., even if the capping failure does not occur during compression molding. It was a big problem.
【0007】また、感光材料の処理工程中、定着工程で
使用する定着剤は主薬となるチオ硫酸塩、保恒剤、硬膜
剤、バッファ剤等により構成されている。感光材料の迅
速処理においては現像反応の停止、キズ、レチキュレー
ション(縮緬皺)等の防止、乾燥性向上のため酸性溶液
中で硬膜剤の含まれる定着液で処理されるが、チオ硫酸
塩は酸性溶液中では不安定で分解して硫黄が遊離析出す
ることが知られている。[0007] In the processing step of the photosensitive material, the fixing agent used in the fixing step is composed of a thiosulfate as a main agent, a preservative, a hardener, a buffering agent and the like. In rapid processing of a photosensitive material, processing is performed with a fixing solution containing a hardener in an acidic solution to stop the development reaction, prevent scratches and reticulation (crepe wrinkles), and improve drying properties. It is known that salts are unstable and decompose in an acidic solution, and sulfur is separated out.
【0008】一方チオ硫酸塩の分解は亜硫酸塩により防
止できることが知られているが、硬膜剤として使用され
るアルミニウム塩が直接接触すると亜硫酸アルミニウム
が析出してしまう。このためチオ硫酸塩と酸剤、アルミ
ニウム塩と亜硫酸塩を含む1パート固体定着剤では析出
による保存性に問題があり、1パート定着固体定着剤の
製造は困難であった。[0008] On the other hand, it is known that the decomposition of thiosulfate can be prevented by sulfite, but aluminum sulfite is deposited when aluminum salt used as a hardener is in direct contact. Therefore, a one-part solid fixing agent containing a thiosulfate and an acid agent, and an aluminum salt and a sulfite has a problem in storage stability due to precipitation, and it is difficult to produce a one-part fixed solid fixing agent.
【0009】従って、キャッピング故障がなく、供給性
のよい1パート固体処理剤の開発が望まれていた。Therefore, there has been a demand for the development of a one-part solid processing agent which has no capping failure and has good supply properties.
【0010】[0010]
【発明が解決しようとする課題】従って、本発明の目的
は、自動現像機処理に適した保存性、安定性の改良され
固体処理剤、感光材料用固体処理剤の可撓性包装体及び
投入方法を提供することにある。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a solid processing agent having improved storage stability and stability which is suitable for processing in an automatic developing machine, a flexible package of a solid processing agent for a photosensitive material, and charging. It is to provide a method.
【0011】[0011]
1.複数の面を有する圧縮成形した錠剤であって、該複
数の面の少なくとも一つの面が凸曲面であることを特徴
とするハロゲン化銀写真感光材料用固体処理剤。1. A solid processing agent for a silver halide photographic light-sensitive material, which is a compression-molded tablet having a plurality of surfaces, wherein at least one of the plurality of surfaces is a convex curved surface.
【0012】2.下記一般式(1)で表される化合物を
含有することを特徴とする1に記載のハロゲン化銀写真
感光材料用固体処理剤。2. 2. The solid processing agent for a silver halide photographic light-sensitive material according to 1, which comprises a compound represented by the following general formula (1).
【0013】一般式(1) R−(O)xSyOzM 〔式中、Rは置換、無置換の脂肪族基、置換、無置換の
芳香族基又は置換、無置換のヘテロ環基を表し、xは0
又は1、yは2又は3、zは2〜8、Mはカチオンを表
す。〕 3.1又は2に記載の錠剤中の成分が少なくとも2つの
成分構成に分かれていることを特徴とするハロゲン化銀
写真感光材料用固体処理剤。[0013] Formula (1) R- (O) x S y O z M [wherein, R is a substituted or unsubstituted aliphatic group, a substituted aromatic group, or a substituted unsubstituted, unsubstituted heterocyclic X represents 0
Or 1, y represents 2 or 3, z represents 2 to 8, and M represents a cation. 3. A solid processing agent for a silver halide photographic light-sensitive material, wherein the components in the tablet according to 1 or 2 are divided into at least two components.
【0014】4.1〜3のいずれか1項に記載の錠剤が
コア及び少なくとも一層の該コアを被覆するシェル層を
有することを特徴とするハロゲン化銀写真感光材料用固
体処理剤。A solid processing agent for a silver halide photographic light-sensitive material, wherein the tablet according to any one of 4.1 to 3 has a core and at least one shell layer covering the core.
【0015】5.複数の面を有し該複数面の少なくとも
一つの面が凸曲面である錠剤をコアとし、少なくとも一
層の該コアを被覆するシェル層を有することを特徴とす
る4に記載のハロゲン化銀写真感光材料用固体処理剤。[0015] 5. 5. The silver halide photographic light-sensitive material according to 4, wherein a tablet having a plurality of surfaces and at least one of the plurality of surfaces is a convex curved surface is used as a core, and at least one shell layer covering the core is provided. Solid processing agent for materials.
【0016】6.水溶性アルミニウム塩を含有する層と
少なくとも一層のチオ硫酸塩を含有する層の間にそれぞ
れの層に不活性な層を設け、圧縮成形したことを特徴と
するハロゲン化銀写真感光材料用固体処理剤。6. Solid processing for a silver halide photographic light-sensitive material, characterized in that an inert layer is provided in each layer between a layer containing a water-soluble aluminum salt and at least one layer containing a thiosulfate, and compression-molded. Agent.
【0017】7.水溶性アルミニウム塩を含有する錠剤
をコアとし、少なくとも一層のチオ硫酸塩を含有するシ
ェル層を有することを特徴とする1〜6のいずれか1項
に記載のハロゲン化銀写真感光材料用固体処理剤。[7] The solid processing for a silver halide photographic light-sensitive material according to any one of claims 1 to 6, wherein a tablet containing a water-soluble aluminum salt is used as a core and a shell layer containing at least one thiosulfate is provided. Agent.
【0018】8.1〜7のいずれか1項に記載の固体処
理剤を複数の片を有する包装体に複数個封入したことを
特徴とするハロゲン化銀写真感光材料用固体処理剤の可
撓性包装体。A flexible solid processing agent for a silver halide photographic light-sensitive material, wherein a plurality of the solid processing agents according to any one of 8.1 to 7 are enclosed in a package having a plurality of pieces. Sex package.
【0019】9.複数の片を有する8に記載の可撓性包
装体であって、該複数の片の少なくとも1片を開いて包
装体中の複数の錠剤を処理装置内に投入することを特徴
とするハロゲン化銀写真感光材料用固体処理剤の投入方
法。9. 9. The flexible package according to 8, wherein the package has a plurality of pieces, wherein at least one of the plurality of pieces is opened and a plurality of tablets in the package are charged into a processing apparatus. How to add a solid processing agent for silver photographic materials.
【0020】以下に本発明を詳しく説明する。Hereinafter, the present invention will be described in detail.
【0021】本発明の感光材料用固体処理剤は、複数の
面を有する圧縮成形した錠剤であって、該複数の面の少
なくとも一つの面が凸曲面である。The solid processing agent for a light-sensitive material of the present invention is a compression-molded tablet having a plurality of surfaces, wherein at least one of the plurality of surfaces is a convex curved surface.
【0022】本発明の錠剤の形状としては、上述のよう
に複数の面の少なくとも一つの面が凸曲面であれば、球
体、円筒(円柱)体、円錐体、角筒(角柱)体、角錐
体、立方体等がいずれの形状でも良いが、好ましくは円
筒体、円錐体が挙げられる。特に円筒体が本発明の効果
及び製造上好ましい。The shape of the tablet of the present invention may be a sphere, a cylinder (a cylinder), a cone, a prism (a prism), a pyramid if at least one of the plurality of surfaces is a convex curved surface as described above. A body, a cube, and the like may be in any shape, but a cylinder and a cone are preferred. In particular, a cylindrical body is preferable in terms of the effects of the present invention and production.
【0023】本発明の錠剤の1錠当たりの大きさとして
は体積にして100〜100000mm3が取扱い上、
及び製造上好ましい。更に好ましくは250〜1500
0mm3であり、特に好ましくは500〜10000m
m3である。The size of the tablet of the present invention per tablet is 100 to 100,000 mm 3 in terms of handling.
And in production. More preferably, 250 to 1500
0 mm 3 , particularly preferably 500 to 10000 m
m is 3.
【0024】更に本発明において錠剤の形状が円筒体形
状の場合、好ましい円筒体の円の直径としては、5〜4
0mmであり、特に10〜30mmが好ましい。更に円
筒体の高さ(最大厚み長)としては1.5〜18mmで
あることが好ましく、特に3〜15mmが好ましい。In the present invention, when the shape of the tablet is cylindrical, the diameter of the circle of the cylindrical body is preferably 5 to 4
0 mm, and particularly preferably 10 to 30 mm. Further, the height (maximum thickness length) of the cylindrical body is preferably 1.5 to 18 mm, and particularly preferably 3 to 15 mm.
【0025】少なくとも一つの面が凸曲面である錠剤の
具体例としては、以下、図1に示す錠剤の断面図に基づ
いて構造上の特徴を説明するが、本発明は図1に限定さ
れるものではない。As a specific example of a tablet having at least one surface having a convex curved surface, the structural features will be described below based on the cross-sectional view of the tablet shown in FIG. 1, but the present invention is limited to FIG. Not something.
【0026】図1は本発明の一例を示す錠剤の断面図で
ある。FIG. 1 is a sectional view of a tablet showing an example of the present invention.
【0027】図1(A)は通常、普通R面錠剤と呼ばれ
ている錠剤の断面を表し、例えば図1(A)において、
直径30mmのときRは半径34mmの円周であり、直
径21mmのときRは半径25mmの円周であり、直径
9mmのときRは半径13mmの円周である。FIG. 1A shows a cross section of a tablet usually called an R-side tablet. For example, in FIG.
When the diameter is 30 mm, R is a circumference having a radius of 34 mm, when the diameter is 21 mm, R is a circumference having a radius of 25 mm, and when the diameter is 9 mm, R is a circumference having a radius of 13 mm.
【0028】図1(B)は通常、糖衣R面錠剤と呼ばれ
ている錠剤の断面を表し、例えば図1(B)において直
径30mmのときRは半径28.5mmの円周であり、
直径21mmのときのRは半径19.5mmの円周であ
り、直径9mmのときのRは半径7.5mmの円周であ
る。FIG. 1B shows a cross section of a tablet usually called a sugar-coated R-face tablet. For example, in FIG. 1B, when the diameter is 30 mm, R is a circumference having a radius of 28.5 mm,
When the diameter is 21 mm, R is a circumference having a radius of 19.5 mm, and when the diameter is 9 mm, R is a circumference having a radius of 7.5 mm.
【0029】図1(C)は通常、スミマル平面錠剤と呼
れている錠剤の断面を表し、例えば図1(C)において
直径30mmのときRは半径7.5mmの円周で、Hは
1.2mmである。直径21mmのときRは半径5.2
mmの円周であり、Hは0.84mm、直径9mmのと
きRは半径2.2mmの円周であり、Hは0.36mm
となる。図1(D)は通常、2段R面錠剤と呼ばれてい
る錠剤の断面を表し、例えば図1(D)において直径3
0mmのときRは半径31.5mmの円周であり、rは
半径12mmの円周であり、Hは5mm、直径21mm
のときRは半径22.5mmの円周であり、rは半径
8.4mmの円周であり、Hは3.5mm、直径9mm
のときRは半径10.5mmの円周であり、rは半径
3.6mmの円周であり、Hは1.5mmである。図1
(E)は錠剤の帯部αが凸曲面である錠剤の断面を表
し、例えば直径30mmでHが10mmのときRは半径
5mmの円周であり、直径21mmでHが7mmのとき
Rは半径3.5mmの円周である。尚、各図中のR、r
は球面の曲率半径を示す。また、上記直径とは、円筒型
錠剤の円の直径を意味する。FIG. 1 (C) shows a cross section of a tablet usually called a semi-flat tablet. For example, in FIG. 1 (C), when the diameter is 30 mm, R is a circumference having a radius of 7.5 mm, and H is 1 .2 mm. When the diameter is 21 mm, R is 5.2.
H is 0.84 mm, R is a circle having a radius of 2.2 mm when the diameter is 9 mm, and H is 0.36 mm.
Becomes FIG. 1 (D) shows a cross section of a tablet usually called a two-stage R-face tablet. For example, in FIG.
When 0 mm, R is a circumference having a radius of 31.5 mm, r is a circumference having a radius of 12 mm, H is 5 mm, and a diameter is 21 mm.
In the above, R is a circumference having a radius of 22.5 mm, r is a circumference having a radius of 8.4 mm, H is 3.5 mm and a diameter is 9 mm.
In this case, R is a circumference having a radius of 10.5 mm, r is a circumference having a radius of 3.6 mm, and H is 1.5 mm. FIG.
(E) represents the cross section of the tablet in which the band portion α of the tablet is a convex curved surface. For example, when the diameter is 30 mm and H is 10 mm, R is a circumference having a radius of 5 mm, and when the diameter is 21 mm and H is 7 mm, R is the radius. The circumference is 3.5 mm. In addition, R, r in each figure
Indicates the radius of curvature of the spherical surface. The above-mentioned diameter means the diameter of the circle of the cylindrical tablet.
【0030】更に図1(A)〜(D)は錠剤の上側、下
側にそれぞれ凸曲面を有するが上側のみ、又は下側のみ
の凸曲面を有しても良く、ある特定の一部分のみ凸曲面
を有しても良い。図1(E)の錠剤においては円周の全
てが凸曲面を有する錠剤であるが円周のある特定の一部
分のみ凸曲面を有しても良い。1 (A) to 1 (D) have convex curved surfaces on the upper and lower sides of the tablet, respectively, but may have convex curved surfaces only on the upper side or only on the lower side. It may have a curved surface. In the tablet of FIG. 1 (E), the entire circumference has a convex curved surface, but only a specific part of the circumference may have a convex curved surface.
【0031】本発明の固体処理剤は前記一般式(1)で
表される化合物を含有することが好ましい。含有量とし
ては固体処理剤の総重量の0.01〜3.0%が好まし
く、より好ましくは0.1〜2.5%、更に好ましくは
0.5〜2.0%である。The solid processing agent of the present invention preferably contains the compound represented by the general formula (1). The content is preferably 0.01 to 3.0%, more preferably 0.1 to 2.5%, and still more preferably 0.5 to 2.0% of the total weight of the solid processing agent.
【0032】一般式(1)において、Rで表される脂肪
族基としては、アルキル基、アルケニル基、アルキニル
基などがあり、アルキル基としては、例えばメチル、エ
チル、i−プロピル、ブチル、t−ブチル、ペンチル、
シクロペンチル、ヘキシル、シクロヘキシル、オクチ
ル、ドデシル等の各基が挙げられる。これらのアルキル
基は、更にハロゲン原子(例えば塩素、臭素、フッ素等
のハロゲン原子)、アルコキシ基(例えばメトキシ、エ
トキシ、1,1−ジメチルエトキシ、ヘキシルオキシ、
ドデシルオキシ等の各基)、アリールオキシ基(例えば
フェノキシ、ナフチルオキシ等の各基)、アリール基
(例えばフェニル、ナフチル等の各基)、アルコキシカ
ルボニル基(例えばメトキシカルボニル、エトキシカル
ボニル、ブトキシカルボニル、2−エチルヘキシルカル
ボニル等の各基)、アリールオキシカルボニル基(例え
ばフェノキシカルボニル、ナフチルオキシカルボニル等
の各基)、アルケニル基(例えばビニル、アリル等の各
基)、複素環基(例えば2−ピリジル、3−ピリジル、
4−ピリジル、モルホリル、ピペリジン、ピペラジル、
ピリミジン、ピラゾリン、フリル等の各基)、アルキニ
ル基(例えばプロパルギル基等)、アミノ基(例えばア
ミノ、N,N−ジメチルアミノ、アニリノ等の各基)、
シアノ基、スルホアミド基(例えばメチルスルホニルア
ミノ、エチルスルホニルアミノ、ブチルスルホニルアミ
ノ、オクチルスルホニルアミノ、フェニルスルホニルア
ミノ等の各基)によって置換されてもよい。In the general formula (1), examples of the aliphatic group represented by R include an alkyl group, an alkenyl group, and an alkynyl group. Examples of the alkyl group include methyl, ethyl, i-propyl, butyl, and t. -Butyl, pentyl,
Each group includes cyclopentyl, hexyl, cyclohexyl, octyl, dodecyl and the like. These alkyl groups further include a halogen atom (for example, a halogen atom such as chlorine, bromine, and fluorine), and an alkoxy group (for example, methoxy, ethoxy, 1,1-dimethylethoxy, hexyloxy,
Groups such as dodecyloxy), aryloxy groups (such as phenoxy and naphthyloxy), aryl groups (such as phenyl and naphthyl), and alkoxycarbonyl groups (such as methoxycarbonyl, ethoxycarbonyl and butoxycarbonyl). Groups such as 2-ethylhexylcarbonyl), aryloxycarbonyl groups (such as phenoxycarbonyl and naphthyloxycarbonyl), alkenyl groups (such as vinyl and allyl) and heterocyclic groups (such as 2-pyridyl, 3-pyridyl,
4-pyridyl, morpholyl, piperidine, piperazil,
Pyrimidine, pyrazoline, furyl, etc.), alkynyl group (eg, propargyl group), amino group (eg, amino, N, N-dimethylamino, anilino, etc.),
It may be substituted by a cyano group or a sulfonamide group (for example, each group such as methylsulfonylamino, ethylsulfonylamino, butylsulfonylamino, octylsulfonylamino, and phenylsulfonylamino).
【0033】アルケニル基としては、例えばビニル基、
アリル基等が挙げられ、アルキニル基としては例えばプ
ロパルギル基が挙げられる。Examples of the alkenyl group include a vinyl group,
Examples include an allyl group and the like, and examples of the alkynyl group include a propargyl group.
【0034】Rで表される芳香族基としては、例えばフ
ェニル基、ナフチル基等が挙げられる。Examples of the aromatic group represented by R include a phenyl group and a naphthyl group.
【0035】Rで表される複素環基としては、例えばピ
リジル基(2−ピリジル、3−ピリジル、4−ピリジル
等の各基)、チアゾリル基、オキサゾリル基、イミダゾ
リル基、フリル基、チェニル基、ピロリル基、ピラジニ
ル基、ピリミジニル基、ピリダジニル基、セレナゾリル
基、スルホラニル基、ピペジリニル基、ピラゾリル基、
テトラゾリル基等が挙げられる。Examples of the heterocyclic group represented by R include a pyridyl group (each group such as 2-pyridyl, 3-pyridyl, 4-pyridyl), a thiazolyl group, an oxazolyl group, an imidazolyl group, a furyl group, a phenyl group, A pyrrolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a selenazolyl group, a sulfolanyl group, a pipedilinyl group, a pyrazolyl group,
And a tetrazolyl group.
【0036】上記、アルケニル基、アルキニル基、芳香
族基、複素環基は、いずれもRで表されるアルキル基及
びアルキル基の置換基、置換原子として示した基、原子
と同様な基、原子によって置換することができる。The alkenyl group, alkynyl group, aromatic group and heterocyclic group are all the alkyl groups represented by R, the substituents of the alkyl groups, the groups shown as the substituted atoms, the groups and atoms similar to the atoms and the atoms. Can be replaced by
【0037】Mで表されるカチオンとしては、好ましく
は金属イオン又は有機カチオンである。金属イオンとし
ては、例えばリチウムイオン、ナトリウムイオン、カリ
ウムイオン等が挙げられ、有機カチオンとしては、例え
ばアンモニウムイオン(アンモニウム、テトラメチルア
ンモニウム、テトラブチルアンモニウム等の各イオ
ン)、ホスホニウムイオン(例えばテトラフェニルホス
ホニウムイオン等)、グアニジルイオン等が挙げられ
る。The cation represented by M is preferably a metal ion or an organic cation. Examples of the metal ion include a lithium ion, a sodium ion, and a potassium ion. Examples of the organic cation include an ammonium ion (each ion such as ammonium, tetramethylammonium, and tetrabutylammonium) and a phosphonium ion (eg, tetraphenylphosphonium). Ion), guanidyl ion and the like.
【0038】一般式(1)で表される化合物は、固体処
理剤を圧縮成形により錠剤状にする際に含有させること
で圧縮成型時の滑沢性を改良するが更に錠剤表面の摩擦
係数を低下させ、キャッピング故障などを防ぐことがで
き、特に接触面積が小さい程、特異的に摩擦係数を低下
させることが分かった。The compound represented by the general formula (1) improves lubricity at the time of compression molding by adding a solid processing agent when it is formed into a tablet by compression molding, but further reduces the friction coefficient of the tablet surface. It has been found that the friction coefficient can be specifically reduced as the contact area becomes smaller, especially when the contact area is small.
【0039】以下に一般式(1)で表される化合物の具
体例を挙げるが、本発明はこれらに限定されるものでは
ない。Specific examples of the compound represented by the general formula (1) are shown below, but the present invention is not limited thereto.
【0040】1−1 C2H5SO3Na 1−2 CH3(CH2)6SO3Na 1−3 CH3(CH2)7SO3Na 1−4 CH3(CH2)5OSO3Na 1−5 CH3(CH2)6OSO3Na 1−6 CH3(CH2)7OSO3Na 1−7 CH3O(CH2)2SO3Na1-1 C 2 H 5 SO 3 Na 1-2 CH 3 (CH 2 ) 6 SO 3 Na 1-3 CH 3 (CH 2 ) 7 SO 3 Na 1-4 CH 3 (CH 2 ) 5 OSO 3 Na 1-5 CH 3 (CH 2 ) 6 OSO 3 Na 1-6 CH 3 (CH 2) 7 OSO 3 Na 1-7 CH 3 O (CH 2) 2 SO 3 Na
【0041】[0041]
【化1】 Embedded image
【0042】本発明の錠剤中の成分は、少なくとも2つ
の成分構成に分かれている。これら少なくとも2つの成
分構成に分けて圧縮成形する方法としては例えば特開平
5−134362号に開示されているように成分の異な
る2種以上の粉粒体を層状に積み重ねて圧縮成形する方
法が挙げられる。このような錠剤は一般に多層錠と呼ば
れ錠剤打錠機(圧縮成形機)の臼の中に異なる成分の粉
粒体を順次充填した後、圧縮して錠剤にするか、一つの
成分の粉粒体を充填ごとに圧縮していき錠剤にする方法
がある。この多層錠剤を含めた本発明の少なくとも2つ
の成分に分かれた錠剤の具体例を図2の(F)〜(K)
に例示するが、本発明はこれらに限定されるものではな
い。なお、図2の(F)〜(K)において模様の違いは
成分の違いを表す。The components in the tablet of the present invention are divided into at least two components. As a method of compression molding by dividing the composition into at least two components, for example, a method in which two or more kinds of powders having different components are stacked in layers and compression molded as disclosed in JP-A-5-134362 is mentioned. Can be Such a tablet is generally called a multi-layer tablet, and the powder of different components is sequentially filled in a die of a tablet tableting machine (compression molding machine), and then compressed into a tablet or a powder of one component is compressed. There is a method in which granules are compressed into tablets each time they are filled. Specific examples of the tablet divided into at least two components of the present invention including this multilayer tablet are shown in FIGS.
However, the present invention is not limited to these. In FIG. 2 (F) to (K), the difference in pattern indicates the difference in component.
【0043】更に本発明の錠剤はコア(核)及び、少な
くとも一層の該コアを被覆するシェル(殻)層を有する
コア/シェル構造を有する。コア/シェル構造を有する
錠剤は一般に有核錠と呼ばれている。Further, the tablet of the present invention has a core / shell structure having a core (core) and at least one shell layer covering the core. Tablets having a core / shell structure are commonly referred to as dry-coated tablets.
【0044】更にコア/シェル構造を有する錠剤は、コ
アが複数の面を有し該複数面の少なくとも一つの面が凸
曲面である錠剤であることが好ましい。Further, the tablet having a core / shell structure is preferably a tablet wherein the core has a plurality of surfaces and at least one of the plurality of surfaces is a convex curved surface.
【0045】コアとシェルの体積比(コア体積Vc/シ
ェル体積Vs)の好ましい範囲としては1/300〜1
/1.5であり、より好ましくは1/150〜1/2で
あり、特に好ましくは1/100〜1/10である。A preferable range of the volume ratio between the core and the shell (core volume Vc / shell volume Vs) is 1/300 to 1
/1.5, more preferably 1/150 to 1/2, and particularly preferably 1/100 to 1/10.
【0046】これらコア/シェル構造を有する錠剤の具
体例を図3の(L)〜(R)に例示するが、本発明はこ
れらに限定されるものではない。なお、図3の(L)〜
(R)において模様の違いは成分の違いを表す。Specific examples of these tablets having a core / shell structure are shown in FIGS. 3 (L) to 3 (R), but the present invention is not limited thereto. In addition, (L) of FIG.
In (R), the difference in pattern indicates the difference in components.
【0047】なお、凸曲面を有しない錠剤の形状を図4
(S)に示す。The shape of the tablet having no convex curved surface is shown in FIG.
(S) shows.
【0048】本発明の錠剤は定着剤、現像剤に適用され
る。The tablet of the present invention is applied to a fixing agent and a developer.
【0049】錠剤を定着剤に適用した錠剤(以下、定着
錠剤)及び該錠剤を溶解して得られる定着液について説
明する。A tablet obtained by applying a tablet as a fixing agent (hereinafter referred to as a fixing tablet) and a fixing solution obtained by dissolving the tablet will be described.
【0050】本発明の定着錠剤は、水溶性アルミニウム
塩及びチオ硫酸塩を含有するが、水溶性アルミニウム塩
を含有する層と少なくとも一層のチオ硫酸塩を含有する
層との間に、それぞれの層に不活性な層を有する錠剤で
ある。The fixing tablet of the present invention contains a water-soluble aluminum salt and a thiosulfate, and each layer is provided between a layer containing a water-soluble aluminum salt and at least one layer containing a thiosulfate. Tablet having an inert layer.
【0051】不活性な層を構成する物質としては、例え
ば水溶性ポリマー類が挙げられる。具体的には水溶性セ
ルロース類、水溶性デキストリン類、水溶性ポリエチレ
ングリコール類、水溶性ポリビニルピロリドン類、水溶
性ポリアクリルアミド類等が使用できる。The substance constituting the inert layer includes, for example, water-soluble polymers. Specifically, water-soluble celluloses, water-soluble dextrins, water-soluble polyethylene glycols, water-soluble polyvinylpyrrolidones, water-soluble polyacrylamides and the like can be used.
【0052】更に本発明の定着錠剤は、水溶性アルミニ
ウム塩を含有するコアと、少なくとも一層のチオ硫酸塩
を含有するシェル層を有する錠剤である。Further, the fixing tablet of the present invention is a tablet having a core containing a water-soluble aluminum salt and a shell layer containing at least one thiosulfate.
【0053】また更に、少なくとも水溶性アルミニウム
塩を含有するコアと少なくともチオ硫酸塩を含有するシ
ェルの間に該コア、シェルそれぞれに上記した不活性な
層を設けて圧縮成形した錠剤であることが好ましい。Further, the tablet may be compression-molded by providing the above-mentioned inert layer on each of the core and the shell between a core containing at least a water-soluble aluminum salt and a shell containing at least a thiosulfate. preferable.
【0054】水溶性アルミニウム塩としてはカリ明礬、
アンモニウム明礬、焼明礬、焼アンモニウム明礬、塩化
アルミニウム、塩化アルミニウムカリウム、硫酸アルミ
ニウム塩等が挙げられる。好ましくは下記一般式(2)
で表される硫酸アルミニウム塩が好ましく用いられる。As the water-soluble aluminum salt, potassium alum,
Examples include ammonium alum, calcined alum, calcined ammonium alum, aluminum chloride, aluminum potassium chloride, and aluminum sulfate. Preferably, the following general formula (2)
Is preferably used.
【0055】一般式(2) Al2(SO4)3・nH2O (n=1〜20) ここでnは平均数を表し、より好ましくは4〜18、特
に好ましくは6〜12である。nの平均数とは、nが異
なる含水塩が混在する場合の平均値を意味する。Formula (2) Al 2 (SO 4 ) 3 .nH 2 O (n = 1 to 20) where n represents an average number, more preferably 4 to 18, and particularly preferably 6 to 12. . The average number of n means an average value when hydrate salts in which n differs are mixed.
【0056】本発明の定着錠剤を溶解した定着液中の硫
酸アルミニウムの濃度としては定着液1リットル当た
り、0.001〜0.5モル、好ましくは0.005〜
0.3モル、特に0.01〜0.1モルが好ましい。The concentration of aluminum sulfate in the fixing solution in which the fixing tablet of the present invention is dissolved is 0.001 to 0.5 mol, preferably 0.005 to 0.5 mol per liter of the fixing solution.
0.3 mol, particularly 0.01 to 0.1 mol, is preferred.
【0057】本発明の定着錠剤は、有機酸若しくは有機
酸塩を含有することが好ましいが、少なくとも水溶性ア
ルミニウム塩含有する層及び/又はコアに含有すること
が好ましい。The fixing tablet of the present invention preferably contains an organic acid or an organic acid salt, but preferably contains at least a layer and / or a core containing a water-soluble aluminum salt.
【0058】本発明の定着錠剤に好ましく用いられる有
機酸とは有機化合物のうち、酸性を示すものを言う。本
発明に好ましく用いられる有機酸塩とは、該有機酸が水
酸化アルカリ又は水酸化アンモニウムと反応して生成し
た水に可溶な塩をいう。The organic acid preferably used in the fixing tablet of the present invention refers to an organic compound which exhibits acidity. The organic acid salt preferably used in the present invention is a water-soluble salt formed by reacting the organic acid with an alkali hydroxide or ammonium hydroxide.
【0059】有機酸としては、カルボン酸類、スルホン
酸類、スルフィン酸類、フェノール類、エノール類、チ
オール類、酸アミド類、オキシム類、スルファアミド類
等が挙げられるが、これらの中ででカルボン酸類、スル
ホン酸類、スルフィン酸類が好ましく、特にカルボン酸
類が好ましい。Examples of the organic acid include carboxylic acids, sulfonic acids, sulfinic acids, phenols, enols, thiols, acid amides, oximes, sulfamides and the like. Acids and sulfinic acids are preferred, and carboxylic acids are particularly preferred.
【0060】カルボン酸類としては、ギ酸、酢酸、安息
香酸、シュウ酸、マロン酸、コハク酸、グルタル酸、ア
ジピン酸、マレイン酸、酒石酸、リンゴ酸、フマル酸、
フタル酸、クエン酸、アコニット酸等が挙げられる。Examples of the carboxylic acids include formic acid, acetic acid, benzoic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, maleic acid, tartaric acid, malic acid, fumaric acid,
Examples include phthalic acid, citric acid, aconitic acid and the like.
【0061】更に有機酸塩類としては上記したカルボン
酸類の塩が挙げられる。例えば酢酸ナトリウム、クエン
酸カリウム、クエン酸リチウム、クエン酸ナトリウム、
クエン酸アンモニウム、酒石酸水素リチウム、酒石酸水
素カリウム、酒石酸カリウム、酒石酸水素ナトリウム、
酒石酸ナトリウム、酒石酸水素アンモニウム、酒石酸ア
ンモニウムカリウム、酒石酸ナトリウムカリウム、リン
ゴ酸ナトリウム、リンゴ酸アンモニウム、コハク酸ナト
リウム、コハク酸アンモニウムなどに代表されるものが
挙げられる。Further, examples of the organic acid salts include salts of the above-mentioned carboxylic acids. For example, sodium acetate, potassium citrate, lithium citrate, sodium citrate,
Ammonium citrate, lithium bitartrate, potassium bitartrate, potassium tartrate, sodium bitartrate,
Examples thereof include those represented by sodium tartrate, ammonium hydrogen tartrate, potassium ammonium tartrate, sodium potassium tartrate, sodium malate, ammonium malate, sodium succinate, ammonium succinate, and the like.
【0062】本発明の定着錠剤が含有するチオ硫酸塩
は、具体的には、リチウム、カリウム、ナトリウム、ア
ンモニウムの塩として用いられるが、好ましくは、チオ
硫酸アンモニウム及びチオ硫酸ナトリウム塩として用い
ることにより、定着速度の速い定着液が得られる。The thiosulfate contained in the fixing tablet of the present invention is specifically used as a salt of lithium, potassium, sodium and ammonium. Preferably, the thiosulfate is used as ammonium thiosulfate and sodium thiosulfate. A fixing solution having a high fixing speed can be obtained.
【0063】本発明の定着錠剤は、亜硫酸塩を含有する
ことが好ましい。亜硫酸塩としては、リチウム、カリウ
ム、ナトリウム、アンモニウム塩等が用いられ、好まし
くは亜硫酸ナトリウムである。またメタ重亜硫酸塩も好
ましく用いられ、特にメタ重亜硫酸ナトリウムが好まし
い。本発明の錠剤の亜硫酸塩及び/又はメタ重亜硫酸塩
はチオ硫酸塩を含有する層又はシェルに含有させること
が好ましい。The fixing tablet of the present invention preferably contains a sulfite. As the sulfite, lithium, potassium, sodium, ammonium salts and the like are used, and preferably sodium sulfite. Also, metabisulfite is preferably used, and sodium metabisulfite is particularly preferable. The sulfite and / or metabisulfite of the tablet of the present invention is preferably contained in a layer or shell containing thiosulfate.
【0064】本発明の定着錠剤は、定着主薬として沃化
物塩やチオシアン酸塩などを加えても良い。The fixing tablet of the present invention may contain an iodide salt or a thiocyanate as a fixing agent.
【0065】更にキレート剤を含有させても良い。例え
ばニトリロ三酢酸、エチレンジアミン四酢酸などのアミ
ノポリカルボン酸類及びこれらの塩などが挙げられる。Further, a chelating agent may be contained. Examples thereof include aminopolycarboxylic acids such as nitrilotriacetic acid and ethylenediaminetetraacetic acid, and salts thereof.
【0066】更に界面活性剤を含有させても良い。例え
ば硫酸エステル化物、スルホン化物などのアニオン活性
剤、ポリエチレングリコール系、エステル系などのノニ
オン界面活性剤、両性活性剤などが挙げられる。Further, a surfactant may be contained. Examples thereof include anionic surfactants such as sulfated and sulfonated compounds, nonionic surfactants such as polyethylene glycol and ester, and amphoteric surfactants.
【0067】更に湿潤剤を含有させても良い。例えばア
ルカノールアミン、アルキレングリコールなどが挙げら
れる。Further, a wetting agent may be contained. For example, alkanolamine, alkylene glycol and the like can be mentioned.
【0068】更に定着促進剤を含有させても良い。例え
ばチオ尿素誘導体、分子内に三重結合を有するアルコー
ル、チオエーテルなどが挙げられる。Further, a fixing accelerator may be contained. For example, thiourea derivatives, alcohols having a triple bond in the molecule, thioethers and the like can be mentioned.
【0069】本発明の錠剤を水に溶解して得られる定着
液のpHは3.8以上が好ましく、より好ましくは4.
2〜5.5である。The pH of the fixing solution obtained by dissolving the tablet of the present invention in water is preferably 3.8 or more, more preferably 4.
2 to 5.5.
【0070】次に本発明の錠剤を現像剤に適用した錠剤
(以下、現像錠剤)及び該現像錠剤を溶解して得られる
現像液について説明する。Next, a tablet obtained by applying the tablet of the present invention to a developer (hereinafter referred to as a “developed tablet”) and a developer obtained by dissolving the developed tablet will be described.
【0071】本発明の現像錠剤は、現像主薬として、レ
ダクトン類、特にアスコルビン酸及び/又はエリソルビ
ン酸(立体異性)及びそれらの塩を含有することが好ま
しい。The developing tablet of the present invention preferably contains, as a developing agent, reductones, particularly ascorbic acid and / or erythorbic acid (stereoisomer) and salts thereof.
【0072】更に以下のような現像主薬を含有しても良
い。ジヒドロキシベンゼン類(例えば、ハイドロキノ
ン、クロロハイドロキノン、ブロモハイドロキノン、ジ
クロロハイドロキノン、イソプロピルハイドロキノン、
メチルハイドロキノン、2,3−ジクロロハイドロキノ
ン、メトキシハイドロキノン、2,5−ジメチルハイド
ロキノン、ハイドロキノンモノスルホン酸カリウム、ハ
イドロキノンモノスルホン酸ナトリウムなど)3−ピラ
ゾリドン類(例えば、1−フェニル−3−ピラゾリド
ン、1−フェニル−4−メチル−3−ピラゾリドン、1
−フェニル−4,4−ジメチル−3−ピラゾリドン、1
−フェニル−4−エチル−3−ピラゾリドン、1−フェ
ニル−5−メチル−3−ピラゾリドン、1−フェニル−
4−メチル−4−ヒドロキシメチル−3−ピラゾリド
ン、1−フェニル−4,4−ジヒドロキシメチル−3−
ピラゾリドン、1−p−トリル−3−ピラゾリドン、1
−フェニル−2−アセチル−4,4−ジメチル−3−ピ
ラゾリドン、1−(2−ベンゾチアゾール)−3−ピラ
ゾリドン、3−アセトキシ−1−フェニル−3−ピラゾ
リドンなど)、アミノフェノール類(例えば、o−アミ
ノフェノール、p−アミノフェノール、N−メチル−o
−アミノフェノール、N−メチル−p−アミノフェノー
ル、2,4−ジアミノフェノールなど)、1−アリル−
3−アミノピラゾリン類(例えば、1−(p−ヒドロキ
シフェニル)−3−アミノピラゾリン、1−(p−メチ
ルアミノフェニル)−3−アミノピラゾリン、1−(p
−アミノ−m−メチルフェニル)−3−アミノピラゾリ
ンなど)、ピラゾロン類(例えば、4−アミノピラゾロ
ン)など、或いはこれらの混合物がある。Further, the following developing agents may be contained. Dihydroxybenzenes (for example, hydroquinone, chlorohydroquinone, bromohydroquinone, dichlorohydroquinone, isopropylhydroquinone,
Methylhydroquinone, 2,3-dichlorohydroquinone, methoxyhydroquinone, 2,5-dimethylhydroquinone, potassium hydroquinone monosulfonate, sodium hydroquinone monosulfonate, etc. 3-pyrazolidones (for example, 1-phenyl-3-pyrazolidone, 1- Phenyl-4-methyl-3-pyrazolidone, 1
-Phenyl-4,4-dimethyl-3-pyrazolidone, 1
-Phenyl-4-ethyl-3-pyrazolidone, 1-phenyl-5-methyl-3-pyrazolidone, 1-phenyl-
4-methyl-4-hydroxymethyl-3-pyrazolidone, 1-phenyl-4,4-dihydroxymethyl-3-
Pyrazolidone, 1-p-tolyl-3-pyrazolidone, 1
-Phenyl-2-acetyl-4,4-dimethyl-3-pyrazolidone, 1- (2-benzothiazole) -3-pyrazolidone, 3-acetoxy-1-phenyl-3-pyrazolidone, etc., aminophenols (for example, o-aminophenol, p-aminophenol, N-methyl-o
-Aminophenol, N-methyl-p-aminophenol, 2,4-diaminophenol, etc.), 1-allyl-
3-aminopyrazolines (for example, 1- (p-hydroxyphenyl) -3-aminopyrazoline, 1- (p-methylaminophenyl) -3-aminopyrazoline, 1- (p
-Amino-m-methylphenyl) -3-aminopyrazoline, pyrazolones (eg, 4-aminopyrazolone), and the like, or a mixture thereof.
【0073】本発明の現像錠剤は亜硫酸塩及び/又はメ
タ重亜硫酸塩を含有することが好ましい。更に錠剤を溶
解し現像液とした場合の液中の亜硫酸塩量は0.05モ
ル/リットル以上0.3モル/リットル未満、更に0.
1モル/リットル以上0.3モル/リットル未満が好ま
しい。The developing tablet of the present invention preferably contains a sulfite and / or metabisulfite. Further, when the tablet is dissolved to form a developer, the amount of sulfite in the solution is 0.05 mol / L or more and less than 0.3 mol / L, and more preferably 0.1 mol / L or less.
It is preferably from 1 mol / liter to less than 0.3 mol / liter.
【0074】その他、緩衝剤として(例えば炭酸塩、硼
酸、硼酸塩、アルカノールアミンなど)、アルカリ剤、
溶解助剤(ポリエチレングリコール類、及びこれらのエ
ステルなど)、pH調整剤(例えばクエン酸のごとき有
機酸など)、増感剤(例えば四級アンモニウム塩な
ど)、現像促進剤、硬膜剤(例えばグルタールアルデヒ
ドなどのジアルデヒド類)、界面活性剤、さらにカブリ
防止剤としてアゾール系有機カブリ防止剤(例えばイン
ダゾール系、イミダゾール系、ベンツイミダゾール系、
トリアゾール系、ベンツトリアゾール系、テトラゾール
系、チアジアゾール系)、処理液に用いられる水道水中
に混在するカルシウムイオンを隠蔽するための隠蔽剤ヘ
キサメタ燐酸ナトリウム、ヘキサメタ燐酸カルシウム、
ポリ燐酸塩、ヂエチレントリアミン5酢酸等を含有させ
ても良い。In addition, as a buffer (for example, carbonate, boric acid, borate, alkanolamine, etc.), an alkaline agent,
Dissolution aids (eg, polyethylene glycols and esters thereof), pH adjusters (eg, organic acids such as citric acid), sensitizers (eg, quaternary ammonium salts), development accelerators, hardeners (eg, Dialdehydes such as glutaraldehyde), a surfactant, and an azole organic antifoggant as an antifoggant (for example, indazole, imidazole, benzimidazole,
Triazole-based, benztriazole-based, tetrazole-based, thiadiazole-based), concealing agents sodium hexametaphosphate, calcium hexametaphosphate for concealing calcium ions mixed in tap water used in the treatment liquid,
A polyphosphate, ethylene triaminepentaacetic acid, or the like may be contained.
【0075】更に銀汚れ防止剤、例えば特開昭56−2
4347号記載の化合物を用いることもできる。Further, a silver stain preventing agent, for example, JP-A-56-2
The compound described in No. 4347 can also be used.
【0076】更に本発明現像錠剤で得られる現像液のp
Hは10.5以下の範囲のものが好ましく、更に好まし
くは9〜10.0の範囲である。Further, the p of the developing solution obtained from the developing tablet of the present invention is
H is preferably in the range of 10.5 or less, more preferably in the range of 9 to 10.0.
【0077】本発明の現像錠剤で得られる現像液には、
特開昭56−106244号に記載のアルカノールアミ
ンなどのアミノ化合物を用いることができる。The developer obtained from the developing tablet of the present invention includes:
Amino compounds such as alkanolamines described in JP-A-56-106244 can be used.
【0078】この他、本発明の現像錠剤で得られる現像
液にはL.F.A.メソン著「フォトグラフィック・プ
ロセッシング・ケミストリー」フォーカル・プレス社刊
(1966年)の22〜229頁、米国特許第2,19
3,015号、同2,592,364号、特開昭48−
64933号などに記載のものを用いてよい。In addition, the developer obtained from the developing tablet of the present invention includes F. A. Meson, "Photographic Processing Chemistry", Focal Press (1966), pp. 22-229, U.S. Pat.
3,015, 2,592,364, JP-A-48-48
No. 64933 may be used.
【0079】一方、アルカリ剤としては緩衝作用も有す
る炭酸塩が好ましい。炭酸塩としては、炭酸カリウム、
炭酸ナトリウム、炭酸リチウム等が挙げられる。On the other hand, a carbonate having a buffering action is preferable as the alkaline agent. As carbonates, potassium carbonate,
Examples include sodium carbonate and lithium carbonate.
【0080】更に、現像処理液中の炭酸塩量は、0.3
モル/リットル以上0.8モル/リットル未満が好まし
い。Further, the amount of carbonate in the developing solution is 0.3
It is preferably at least mol / l and less than 0.8 mol / l.
【0081】次にハロゲン化銀写真感光材料用処理剤の
固体化について説明する。写真処理剤を固体化するに
は、濃厚液または微粉体ないしは粒状体の写真処理剤と
水溶性結着剤を混練し成型化するか、仮成型した写真処
理剤の表面に水溶性結着剤を噴霧したりすることで被覆
層を形成する等、任意の手段が採用できる(特開平4−
29136号、同4−85535号、同4−85536
号、同4−85533号、同4−85534号、同4−
172341号参照)。Next, the solidification of the processing agent for a silver halide photographic light-sensitive material will be described. In order to solidify the photographic processing agent, the photographic processing agent in the form of a concentrated liquid, a fine powder or a granular material and a water-soluble binder are kneaded and molded, or the water-soluble binder is added to the surface of the temporarily formed photographic processing agent. Any means can be adopted, such as forming a coating layer by spraying on the surface (Japanese Unexamined Patent Publication No.
No. 29136, 4-85535, 4-85536
Nos. 4-85533, 4-85534, 4-
172341).
【0082】好ましい錠剤の製造法としては、単に固体
処理剤成分を混合し圧縮打錠工程により形成しても良い
が、粉末状の固体処理剤を造粒工程で造粒した後、得ら
れた顆粒を圧縮打錠工程にて成形する方法がより好まし
い。As a preferred tablet production method, a solid processing agent component may be simply mixed and formed by a compression tableting step. However, a powdered solid processing agent is granulated in a granulation step and then obtained. A method in which granules are formed in a compression tableting step is more preferable.
【0083】造粒方法としては、転動造粒、押し出し造
粒、圧縮造粒、解砕造粒、攪拌造粒、流動層造粒、噴霧
乾燥造粒等公知の方法を用いることができる。造粒工程
で得られた顆粒の平均粒径は、加圧圧縮(圧縮打錠)す
る際、成分の不均一化、いわゆる偏析が起こりにくいと
いう点で、100〜800μmのものを用いることが好
ましく、より好ましくは200〜750μmである。さ
らに粒度分布は造粒物粒子の60%以上が±100〜1
50μmの偏差内にあるものが好ましい。次に得られた
顆粒を圧縮成形(圧縮打錠)する際には公知の圧縮機、
例えば油圧プレス機、単発式打錠機、ロータリー式打錠
機、ブリケッテングマシン等を用いることが出来る。As the granulation method, known methods such as tumbling granulation, extrusion granulation, compression granulation, crushing granulation, stirring granulation, fluidized bed granulation, and spray drying granulation can be used. The average particle size of the granules obtained in the granulation step is preferably from 100 to 800 μm in that the components are not made uniform, that is, so-called segregation does not easily occur during pressure compression (compression tableting). , More preferably 200 to 750 μm. Further, the particle size distribution is such that 60% or more of the granulated particles are ± 100 to 1
Those with a deviation of 50 μm are preferred. When the obtained granules are subjected to compression molding (compression tableting), a known compressor is used.
For example, a hydraulic press, a single-shot tableting machine, a rotary tableting machine, a briquetting machine, or the like can be used.
【0084】本発明の複数の面の少なくとも一つの面が
凸曲面を有する錠剤は、所望の凸曲面を有する杵及び臼
を装着した上記圧縮機又は所望の凸曲面を有する杵及び
臼を有する打錠機により容易に錠剤成型することができ
る。The tablet of the present invention having at least one of a plurality of surfaces having a convex curved surface can be obtained from the above-described compressor equipped with a punch and a die having a desired convex curved surface or a punch having a punch and a die having a desired convex curved surface. Tablets can be easily formed with a tablet machine.
【0085】本発明の固体処理剤の嵩密度は、0.4g
/cm3〜2.5g/cm3が好ましく、1.0g/cm
3〜2.0g/cm3のものが更に好ましい。The bulk density of the solid processing agent of the present invention is 0.4 g
/ Cm 3 to 2.5 g / cm 3 , preferably 1.0 g / cm 3
Those having 3 to 2.0 g / cm 3 are more preferable.
【0086】本発明の固体処理剤は、ある処理剤の1部
の成分のみ錠剤化することも本発明の範囲に入るが、好
ましくは該処理剤の全成分が錠剤化されていることが好
ましい。The solid processing agent of the present invention falls within the scope of the present invention in that only a part of a certain processing agent is tableted, but preferably all the components of the processing agent are tableted. .
【0087】本発明の錠剤は、各成分が別々の錠剤とし
て成形され、同一包装されてもよい。In the tablet of the present invention, each component may be formed as a separate tablet and packaged in the same manner.
【0088】また、現像剤を固体化する場合、現像主
薬、アルカリ剤、還元剤等、全ての成分を固体処理剤化
し、錠剤に圧縮成型した場合には、少なくとも3剤以
内、即ち1剤にすることができ、又2剤以上に分けて錠
剤化した場合は、これら複数の錠剤が同一包装されてい
る。When the developer is solidified, all components such as a developing agent, an alkaline agent, a reducing agent, etc. are converted into a solid processing agent, and when compression-molded into a tablet, at least 3 or less, ie, 1 agent When two or more tablets are divided into tablets, these tablets are packaged in the same manner.
【0089】処理量情報に応じて各処理槽に補充する処
理剤全てを固体処理剤として投入することが好ましい。
補充水が必要な場合には、処理量情報又は別の補充水制
御情報に基づき補充水が補充される。この場合処理槽に
補充する液体は補充水のみとすることが出来る。つま
り、補充が必要な処理槽が2種類以上の複数であった場
合に、補充水を共有することによって補充用液体を貯留
するタンクは1つで済み、自動現像機のコンパクト化が
図れる。補充水タンクは外部に外置きでも、自動現像機
に内蔵してもよく、内蔵するのは省スペース等の点から
も好ましい。It is preferable that all the processing agents to be replenished into each processing tank according to the processing amount information are charged as solid processing agents.
When replenishing water is required, replenishing water is replenished based on the processing amount information or other replenishing water control information. In this case, the liquid to be replenished to the treatment tank can be only replenishing water. That is, when two or more types of processing tanks need replenishment, only one tank is required to store the replenishing liquid by sharing the replenishing water, and the size of the automatic developing machine can be reduced. The replenishing water tank may be provided outside or externally, or may be built in an automatic developing machine, and the built-in water tank is preferable in terms of space saving and the like.
【0090】本発明の固体処理剤は、複数の片の少なく
とも1片を開いて複数の固体処理剤を投入する可撓性包
装体複数個封入する。The solid processing agent of the present invention is obtained by enclosing at least one of a plurality of pieces and a plurality of flexible packages into which a plurality of solid processing agents are charged.
【0091】本発明の固体処理剤の可撓性包装体及びそ
の投入方法について説明する。A flexible package of the solid processing agent of the present invention and a method for charging the same will be described.
【0092】図5に本発明の複数の片の少なくとも1片
を開いて複数の固体処理剤を投入する可撓性包装体1に
ついて説明する。FIG. 5 illustrates a flexible package 1 according to the present invention in which at least one of a plurality of pieces is opened and a plurality of solid processing agents are charged.
【0093】包装体1は防湿袋5及び防湿袋内部に収容
する内装材2から構成され、内部に本発明の凸曲面を有
する錠剤型固体処理剤Jが収容される。The package 1 is composed of a moisture-proof bag 5 and an interior material 2 housed inside the moisture-proof bag, and the tablet type solid processing agent J having a convex curved surface of the present invention is housed therein.
【0094】図6は内装材2を示したものであり、内装
材には略方形の基板3とその基板の3辺から延伸する部
位4、各々41、42、43を有し〔図6(a)〕、該
延伸する部位が基板に対し同一方向に曲折して各々3面
を形成する〔図6(b)〕。FIG. 6 shows the interior material 2. The interior material has a substantially rectangular substrate 3 and portions 4 extending from three sides of the substrate, 41, 42, and 43, respectively [FIG. a)], the extending portion is bent in the same direction with respect to the substrate to form three surfaces each (FIG. 6 (b)).
【0095】図7(a)は防湿袋の背シール部6に具備
されている開封用部位7を示し、図7(b)は該開封用
部位7を帯状に防湿袋の一部を切り取り開封を行ったと
ころを表す。FIG. 7 (a) shows an opening portion 7 provided in the back seal portion 6 of the moisture-proof bag, and FIG. 7 (b) cuts a part of the moisture-proof bag into a strip shape to open the opening portion 7. Indicates that the test was performed.
【0096】図8は開封された固体処理剤の可撓性包装
体及び該包装体中の固体処理剤Jの状態を表す斜視図で
ある。FIG. 8 is a perspective view showing an opened flexible package of the solid processing agent and the state of the solid processing agent J in the package.
【0097】開封された包装体はその後、自動現像機の
処理剤投入部にセット収容することにより、開封口から
下向きになるように斜めに傾斜され錠剤が滑り落ちるよ
うにして投入される。Thereafter, the opened package is set and accommodated in a processing agent charging section of the automatic developing machine, and is inclined obliquely downward so as to face the opening from the opening, and is loaded so that the tablet slides down.
【0098】収容される錠剤型固体処理剤Jは吸水特性
があるため、防湿性が前記可撓性包装体には要求され
る。Since the contained tablet-type solid processing agent J has a water-absorbing property, the flexible package is required to have moisture-proof properties.
【0099】よって、防湿袋の中間層に3〜20μm望
ましくは5〜10μmのAl層を具備し、さらに最外層
に輸送や取扱い時にピンホールが発生するのを防止する
ため、10〜40μm、望ましくは12〜30μmのP
ET(ポリエチレンテレフタレート)あるいはナイロン
を有している。また、防湿袋内部には略方形の基板の3
辺から延伸する部位4を有し、この3辺が基板に対し折
曲して成る部材であり、可撓性の防湿袋を保持しやすく
かつ錠剤の収容、取り出しが確実に行えるようにしてい
る。Therefore, the intermediate layer of the moisture-proof bag is provided with an Al layer of 3 to 20 μm, preferably 5 to 10 μm, and the outermost layer is preferably 10 to 40 μm in order to prevent the occurrence of pinholes during transportation and handling. Is 12-30 μm P
It has ET (polyethylene terephthalate) or nylon. The inside of the moisture-proof bag has a substantially rectangular substrate.
It has a portion 4 extending from the side, and these three sides are members that are bent with respect to the substrate, so that the flexible moisture-proof bag can be easily held and the tablet can be stored and taken out reliably. .
【0100】前記可撓性の防湿袋は錠剤の収容性及び開
封性、更に自動現像機へのセット性の点よりガセットタ
イプが望ましい。The flexible moisture-proof bag is desirably a gusset type from the viewpoints of tablet accommodating and opening properties, and ease of setting in an automatic developing machine.
【0101】また、防湿袋を確実に開封し収容している
錠剤を自動現像機に間違いなく装填するための、ガセッ
トタイプの防湿袋の背シール部に背シール部から帯状に
開封できる開封用部位7が設けられていることが好まし
い。Further, in order to surely open the moisture-proof bag and load the stored tablet into the automatic developing machine, the gusset-type moisture-proof bag can be opened in a strip shape from the back seal portion to the back seal portion. 7 is preferably provided.
【0102】帯状の幅は5〜25mm、望ましくは8〜
20mmが良い。5mmより幅が小さいと途中で切れて
しまう危険性があり、逆に25mmより大きいと開封が
しづらくなる。The width of the band is 5 to 25 mm, preferably 8 to 25 mm.
20 mm is good. If the width is smaller than 5 mm, there is a risk of being cut off in the middle, and if it is larger than 25 mm, it becomes difficult to open.
【0103】また、帯状の開封を確実にするため袋の横
方向の引張り強度が800kg/m2以下、望ましくは
600kg/m2以下、袋の縦方向の引張り強度が2,
000kg/m2以上、望ましくは2,500kg/m2
以上で厚さが20〜80μmの一軸延伸PE(ポリエチ
レン)を防湿袋の中間層に設けることにより、防湿袋の
帯状の開封が確実に行うことができる。さらに、最内層
として厚さ20〜80μmのLDPE(低密度ポリエチ
レン)あるいはEVA(エチレン−酢酸ビニル共重合
体)を使用することにより、安定したシール性と小さな
力で帯状開封を行うことが可能となる。Further, in order to ensure the opening of the band, the lateral tensile strength of the bag is 800 kg / m 2 or less, preferably 600 kg / m 2 or less, and the longitudinal tensile strength of the bag is 2 kg / m 2 or less.
000kg / m 2 or more, preferably 2,500kg / m 2
As described above, by providing the uniaxially stretched PE (polyethylene) having a thickness of 20 to 80 μm in the intermediate layer of the moisture-proof bag, the band-like opening of the moisture-proof bag can be reliably performed. Furthermore, by using LDPE (low density polyethylene) or EVA (ethylene-vinyl acetate copolymer) having a thickness of 20 to 80 μm as the innermost layer, it is possible to perform a band-like opening with a stable sealing property and a small force. Become.
【0104】防湿袋内部に収容される部材は坪量が10
0〜600g/m2で摩擦係数が0.6以下の紙材、あ
るいは該紙材の少なくとも処理剤が接触する片面に摩擦
係数が0.6以下、厚さが20〜200μmのプラスチ
ックフィルムをラミネートした複合材を使用することに
より錠剤が自動現像機に確実に投入される。The member accommodated in the moisture-proof bag has a basis weight of 10
A paper material having a friction coefficient of 0.6 or less and a thickness of 20 to 200 μm laminated on at least one surface of the paper material having a friction coefficient of 0 to 600 g / m 2 and a friction coefficient of 0.6 or less. The use of the composite material ensures that the tablets are fed into the automatic processor.
【0105】坪量が100g/m2以下であると部材の
強度が弱くなり取扱い時の変形が生じて自動現像機にセ
ットできなくなる可能性がある。If the grammage is less than 100 g / m 2 , the strength of the member becomes weak, causing deformation at the time of handling, which may make it impossible to set the member in an automatic developing machine.
【0106】また、坪量が600g/m2より大きくな
ると略方形の基板の3辺から延伸する部位を折り曲げて
組み立てることが難しくなり作業効率が落ちるばかりか
コスト的にもアップし、好ましくない。On the other hand, if the basis weight is more than 600 g / m 2, it is difficult to bend a portion extending from three sides of a substantially rectangular substrate and assemble it, which not only lowers the working efficiency but also increases the cost, which is not preferable.
【0107】また、内装材2が紙材であると、紙材が水
分を吸収し錠剤に影響を与えるため、本部材の含水量管
理が必要となるが、厚さ0.1〜0.8mm、静摩擦係
数が0.6以下のプラスチックにすれば、水分吸収につ
いて配慮する必要がなくなり、生産工程での管理が非常
に容易になり好ましい。When the interior material 2 is a paper material, the paper material absorbs moisture and affects the tablet, so that the water content of the member must be controlled. It is preferable to use a plastic having a static friction coefficient of 0.6 or less, since it is not necessary to consider moisture absorption, and the management in the production process becomes very easy.
【0108】さらに、図6(c)に示すように内装材2
の略方形の基板3の表面にレール状の凸部8を複数設け
ることにより、錠剤型固体処理剤との接触面積を減少さ
せることができ良好な錠剤投入性を得ることができる。Further, as shown in FIG.
By providing a plurality of rail-shaped projections 8 on the surface of the substantially square substrate 3, the contact area with the tablet-type solid processing agent can be reduced, and good tablet-injection properties can be obtained.
【0109】レール状の凸部の幅は0.5〜10mm、
高さは0.1〜4mmが望ましい。The width of the rail-shaped projection is 0.5 to 10 mm,
The height is desirably 0.1 to 4 mm.
【0110】図8及び図9は該固体処理剤の可撓性包装
体を自動現像機にセット投入する過程を示す1例を表し
たものである。FIGS. 8 and 9 show an example of the process of setting the flexible package of the solid processing agent into an automatic processor.
【0111】図8は自動現像機から処理剤投入部を引き
出し現像剤及び定着剤の固体処理剤の可撓性包装体を装
填部位に準備しようとしている状態を表し、図9は処理
剤投入部に固体処理剤の可撓性包装体を装填後、防湿袋
の背シール部6に具備されている開封用部位7から帯状
に防湿袋の一部を切り取り、開封した後、自動現像機の
処理剤投入部10にセット収容することにより、錠剤が
収容されている前記包装体は、開封口から下向きになる
ように斜めに傾斜され錠剤が滑り落ちるようにして投入
される。FIG. 8 shows a state in which the processing agent feeding section is pulled out of the automatic developing machine and a flexible package of solid processing agent of the developer and the fixing agent is to be prepared at the loading site. FIG. After the flexible package of the solid processing agent is loaded into the bag, a part of the moisture-proof bag is cut out in a strip shape from the opening portion 7 provided on the back seal portion 6 of the moisture-proof bag, and the bag is opened. By storing the tablet in the agent charging section 10, the package in which the tablet is stored is inclined obliquely so as to face downward from the opening and the tablet is loaded so as to slide down.
【0112】[0112]
実施例1 以下、実施例により本発明を説明するが、本発明はこれ
らに限定されるものではない。Example 1 Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited thereto.
【0113】〈固体定着剤の作成〉 〔造粒物(ZA)〕チオ硫酸アンモニウム/チオ硫酸ナ
トリウム(90/10重量比)14580gを市販のバ
ンタムミル中で平均10μmになるまで粉砕する。この
微粉に亜硫酸ナトリウム550g、メタ重亜硫酸ナトリ
ウム750g、パインフロー1220gを加え、水の添
加量を50mlにして撹拌造粒を行い、造粒物を流動層
乾燥機で50℃で乾燥して水分を1.0%(重量比)以
下に除去し、更に1.0mmのメッシュを装着した整粒
機で整粒して造粒物(ZA)を得た。<Preparation of solid fixing agent> [Granulated product (ZA)] In a commercially available bantam mill, 14580 g of ammonium thiosulfate / sodium thiosulfate (90/10 weight ratio) is ground to an average of 10 μm. To this fine powder, 550 g of sodium sulfite, 750 g of sodium metabisulfite, and 1220 g of pine flow were added, and the amount of water was added to 50 ml, and the mixture was stirred and granulated. The granulated product was dried at 50 ° C. with a fluidized bed dryer to remove water. It was removed to 1.0% (weight ratio) or less, and further sized with a sizing machine equipped with a 1.0 mm mesh to obtain a granulated product (ZA).
【0114】〔定着錠剤a、b、cの作製〕このように
して得られた造粒物(ZA)にβ−アラニン3000
g、酢酸ナトリウム4330g、更に、本発明の一般式
(1)で表される化合物No.1−3を総重量の1.5
%となるように添加し、市販のロータリー混合機で5分
間混合した。得られた混合物(KA)を菊水製作所
(株)製タフプレスコレクト1527HUを改造した打
錠機により1錠当たり充填量を10gにして図1の
(A)、(B)及び図4の(S)に示すような形状の錠
剤を成形できる杵及び臼を使用して圧縮打錠を行い、そ
れぞれ円直径30mmの円筒形の定着錠剤a、b、cを
作成した。[Preparation of Fixing Tablets a, b, c] The granules (ZA) thus obtained were added to β-alanine 3000
g, sodium acetate 4330 g, and the compound No. 1 represented by the general formula (1) of the present invention. 1-3 is 1.5 of the total weight
%, And mixed for 5 minutes using a commercially available rotary mixer. The obtained mixture (KA) was adjusted to a filling amount of 10 g per tablet using a tableting machine modified from Tough Press Collect 1527HU manufactured by Kikusui Seisakusho Co., Ltd. to make the filling amount per tablet 10 g, and (S) in FIG. 1 (A), (B) and FIG. Compression tableting was performed using a punch and a die capable of forming a tablet having the shape shown in (1), thereby forming cylindrical fixing tablets a, b, and c each having a circular diameter of 30 mm.
【0115】〔造粒物(ZB)〕ホウ酸600g、硫酸
アルミ・8水塩1480g、琥珀酸1100g、酒石酸
300gを市販のバンタムミル中で平均10μmになる
まで粉砕する。これらの微粉にD−マンニット250
g、D−ソルビット50gを加え、水の添加量を30m
lにして撹拌造粒を行い、造粒物を流動層乾燥機で50
℃で乾燥して水分を1.0%(重量比)以下に除去し、
更に1.0mmのメッシュを装着した整粒機で整粒して
造粒物(ZB)を得た。[Granulated product (ZB)] 600 g of boric acid, 1480 g of aluminum sulfate octahydrate, 1100 g of succinic acid, and 300 g of tartaric acid are pulverized in a commercially available bantam mill to an average of 10 μm. D-Mannit 250 is added to these fine powders.
g, 50 g of D-Sorbit, and the added amount of water is 30 m.
and agitated granulation.
C. to remove water to 1.0% (weight ratio) or less,
The granulated product (ZB) was obtained by sizing with a sizing machine equipped with a 1.0 mm mesh.
【0116】〔定着錠剤d、e、fの作製〕このように
して得られた造粒物(ZB)に酢酸ナトリウム750
g、更に、本発明の一般式(1)で表される化合物N
o.1−3を総重量の1.5%となるように添加し、市
販のロータリー混合機で5分間混合した。得られた混合
物(KB)を菊水製作所(株)製タフプレスコレクト1
527HUを改造した打錠機により1錠当たり充填量を
10gにして図1(A)、(B)及び図4の(S)に示
すような形状の錠剤を成形できる杵及び臼を使用して圧
縮打錠を行い、それぞれ円直径30mmの円筒形の定着
錠剤d、e、fを作成した。[Preparation of Fixing Tablets d, e, f] Sodium acetate 750 was added to the granules (ZB) thus obtained.
g, and the compound N of the present invention represented by the general formula (1)
o. 1-3 was added to 1.5% of the total weight, and mixed for 5 minutes using a commercially available rotary mixer. The obtained mixture (KB) was mixed with Kikusui Seisakusho Co., Ltd. Tough Press Collect 1
Using a punch and a mill capable of forming tablets having the shape shown in FIGS. 1 (A), (B) and (S) in FIG. Compression tableting was performed to prepare cylindrical fixing tablets d, e, and f each having a circular diameter of 30 mm.
【0117】〔錠剤可橈性包装体の作製〕得られた錠剤
a、b、c、d、e、fを内装材が秤量100〜600
g/m2の紙材に厚さ20〜200μmのプラスチック
フイルムを片面ラミネートした複合材料を用い、図5〜
図7に示されている形状の可橈性包装材料にそれぞれ7
0個ずつ包装して錠剤の可橈性包装体を作製した。[Preparation of tablet flexible package] The obtained tablets a, b, c, d, e, and f were weighed with an interior material of 100 to 600.
g / m 2 paper material and a single-sided laminated plastic film with a thickness of 20 to 200 μm was used.
Each of the flexible packaging materials of the shape shown in FIG.
The tablets were packed by 0 to prepare a flexible package of tablets.
【0118】得られた錠剤の硬度、摩擦係数を測定し、
更に溶解性を評価した。The hardness and friction coefficient of the obtained tablet were measured.
Further, the solubility was evaluated.
【0119】〈硬度の評価〉前記操作で得られた錠剤試
料それぞれ20個を硬度測定機(岡田精工社製TS−5
0N)を用いて測定し、その平均値を錠剤試料の硬度
(強度)とし、結果を表1に示した。<Evaluation of Hardness> Twenty tablet samples obtained by the above operation were each measured with a hardness measuring machine (TS-5 manufactured by Okada Seiko Co., Ltd.).
0N), the average value was taken as the hardness (strength) of the tablet sample, and the results are shown in Table 1.
【0120】〈摩擦係数の評価〉含水率5.5%のボー
ル紙に対する摩擦係数を静摩擦係数測定器HEIDEN
−10(新東科学(株)製)を用いて測定した。結果を
表1に示す。<Evaluation of Coefficient of Friction> The coefficient of friction with respect to a cardboard having a water content of 5.5% was measured using a static friction coefficient measuring instrument HEIDEN.
-10 (manufactured by Shinto Kagaku Co., Ltd.). Table 1 shows the results.
【0121】〈溶解性の評価〉それぞれの錠剤試料を5
錠ずつとり30℃に恒温した水道水300ccにマグネ
チックスターラーを用いて撹拌溶解させ、錠剤投入時か
ら全ての錠剤が目視にて完全に溶解するまでの時間を比
較評価し、結果を表1に示した。尚、溶解時間は、この
操作を5回行い5回の平均値である。<Evaluation of solubility>
Each tablet was stirred and dissolved in 300 cc of tap water at a constant temperature of 30 ° C. using a magnetic stirrer, and the time from when the tablets were introduced until all the tablets were completely dissolved was compared and evaluated. The results are shown in Table 1. Indicated. The dissolution time is an average value of five times of performing this operation five times.
【0122】〈投入性の評価〉上記した図5〜図7で示
されている形状の可撓性包装材料に錠剤試料a〜fをそ
れぞれ70錠ずつ包装して可撓性包装体を作製した。こ
の時、錠剤70錠の総体積が包装材料容積の65%にな
るようにした。更に図8、図9に示されている型の自動
現像機の投入部に同図8のように開封したキットをセッ
トし、傾斜角度45度に投入部を傾斜させ錠剤全てが自
動現像機内の溶解槽に投入落下する時間を測定した。測
定はそれぞれ10回ずつ行い、それらの包装材料内の全
錠剤が落下するのに要した平均落下時間を測定して投入
性の評価尺度として表1に示した。従って、投入に要し
た平均時間が小さいものほど投入性がよいことを示す。<Evaluation of Injectability> 70 tablets of each of the tablet samples a to f were packaged in the flexible packaging material having the shape shown in FIGS. 5 to 7 to prepare a flexible package. . At this time, the total volume of the 70 tablets was 65% of the volume of the packaging material. Further, the kit opened as shown in FIG. 8 is set in the input section of the automatic developing machine of the type shown in FIGS. 8 and 9, and the input section is inclined at an inclination angle of 45 degrees so that all the tablets in the automatic developing machine are set. The time of dropping into the dissolution tank was measured. Each measurement was performed 10 times, and the average drop time required for all the tablets in the packaging material to fall was measured. Therefore, it indicates that the smaller the average time required for charging is, the better the charging performance is.
【0123】[0123]
【表1】 [Table 1]
【0124】表1より、比較錠剤cに対して本発明の錠
剤a、b、さらに比較錠剤fに対して本発明の錠剤d、
eは錠剤硬度が高く、含水率5.5%のボール紙に対す
る摩擦係数が小さく、さらに溶解性に優れていることが
分かる。また、本発明の錠剤は比較錠剤より良好な投入
性を有することが分かる。From Table 1, it can be seen that tablets a and b of the present invention correspond to comparative tablet c, and tablets d and v of the present invention correspond to comparative tablet f.
It can be seen that e has a high tablet hardness, a low coefficient of friction with respect to a cardboard having a water content of 5.5%, and is excellent in solubility. Further, it can be seen that the tablet of the present invention has better dosing properties than the comparative tablet.
【0125】図1(A)、(B)の凸曲面を有する形状
の錠剤は凸曲面を有さない図4(S)の錠剤に比べ摩擦
係数が低く滑りやすいため図5〜7に示されているよう
な包装材料に複数の錠剤を包装し、自動現像機にセット
して錠剤を投入する方法において適していることがわか
る。更に本発明の錠剤は大量に感光材料を迅速処理する
自動現像機処理に適していることが判る。The tablets having a convex curved surface shown in FIGS. 1A and 1B have a lower coefficient of friction than the tablets having no convex curved surface shown in FIG. It is understood that the method is suitable for a method of packaging a plurality of tablets in such a packaging material, setting the tablets in an automatic developing machine, and feeding the tablets. Further, it can be seen that the tablet of the present invention is suitable for processing in an automatic developing machine for rapidly processing a large amount of photosensitive material.
【0126】実施例2 〔比較定着錠剤gの作製〕実施例1で得られた混合物
(KA)と(KB)を重量比8.3:1.7の割合でロ
ータリー混合機で5分間混合し、得られた混合物を菊水
製作所(株)製タフプレスコレクト1527HUを改造
した打錠機により1錠当たり充填量を10gにして図4
(S)に示すような形状の錠剤を成形できる杵を使用し
て圧縮打錠を行い、直径30mmの円筒形の比較定着錠
剤gを作成した。Example 2 [Preparation of Comparative Fixing Tablet g] The mixture (KA) and (KB) obtained in Example 1 were mixed at a weight ratio of 8.3: 1.7 by a rotary mixer for 5 minutes. The obtained mixture was adjusted to a filling amount of 10 g per tablet using a tableting machine modified from Tough Press Collect 1527HU manufactured by Kikusui Seisakusho Co., Ltd.
Compression tableting was performed using a punch capable of forming a tablet having a shape as shown in (S) to prepare a cylindrical comparative fixing tablet g having a diameter of 30 mm.
【0127】〔定着錠剤hの作製〕続いて混合物(K
A)と(KB)を両者混合せずに重量比8.3:1.7
の割合になるように菊水製作所(株)製クリーンプレス
コレクト3L51Kを改造した多層回転式打錠機により
1錠当たり充填量を10gにして糖衣R面を有する形状
の錠剤の成形できる杵を使用して圧縮打錠を行い、円直
径30mmの円筒形の図2(F)に示すような二重構造
の定着錠剤hを作成した。[Preparation of Fixing Tablet h] Subsequently, the mixture (K
A) and (KB) are not mixed, and the weight ratio is 8.3: 1.7.
Using a punch capable of forming a tablet having a sugar-coated R surface with a filling amount of 10 g per tablet using a multi-layer rotary tableting machine modified from Clean Press Collect 3L51K manufactured by Kikusui Seisakusho Co., Ltd. Then, compression tableting was performed to produce a cylindrical fixing tablet h having a circular diameter of 30 mm and a double structure as shown in FIG. 2 (F).
【0128】〔定着錠剤iの作製〕次に、クリーンプレ
スコレクト3L51Kを改造した多層回転式打錠機を用
いて下層(第1層)に実施例1の混合物(KA)を8.
3g、上層(第2層)に上記混合物(KB)1.7gが
それぞれ充填される様に調整し、更に第1層と第2層の
間に不活性物質としてポリエチレングリコール平均分子
量4000(PEG4000)を0.1gを充填される
様にして圧縮成形し、糖衣R面を有する形状の図2
(G)に示すような構造を有する円直径30mmの円筒
形定着錠剤iを作成した。[Preparation of Fixing Tablet i] Next, the mixture (KA) of Example 1 was used as the lower layer (first layer) in a lower layer (first layer) using a multi-layer rotary tableting machine modified from Clean Press Collect 3L51K.
3 g and the upper layer (second layer) were each filled with 1.7 g of the above-mentioned mixture (KB), and an average molecular weight of polyethylene glycol 4000 (PEG 4000) was used as an inert substance between the first and second layers. Is compression-molded so as to be filled with 0.1 g, and has a sugar-coated R surface.
A cylindrical fixing tablet i having a circular diameter of 30 mm and a structure as shown in (G) was prepared.
【0129】〔定着錠剤j、kの作製〕次に、混合物
(KB)を菊水製作所(株)製タフプレスコレクト15
27HUを改造した打錠機により1錠当たり充填量を
1.7gにして図1(B)及び図4(S)に示すような
形状の錠剤(それぞれ錠剤j及び錠剤k)を成形できる
杵を使用して圧縮打錠を行い、円直径21mmの円筒形
のそれぞれ定着錠剤j、kを作成した。[Preparation of Fixing Tablets j and k] Next, the mixture (KB) was mixed with Kikusui Seisakusho Co., Ltd. Tough Press Collect 15
A punch capable of forming tablets (tablet j and tablet k, respectively) as shown in FIGS. 1 (B) and 4 (S) with a filling amount of 1.7 g per tablet using a modified tableting machine of 27HU. Then, compression tableting was performed to prepare cylindrical fixing tablets j and k each having a circular diameter of 21 mm.
【0130】〔定着錠剤l、mの作製〕続いて菊水製作
所(株)製クリーンプレスコレクト45DCを改造した
有核回転式打錠機により上記直径21mmの錠剤j、k
がコアとなるように臼内に投入しながら実施例1で得ら
れた混合物(KA)がシェルとなるように圧縮打錠を行
った。尚、1錠当たり重量が10gになるように混合物
(KA)を充填し、糖衣R面を有する形状を成形できる
杵を使用して直径30mmで図3(O)、(L)に示す
ような構造の円筒形コア/シェル定着錠剤l(コアが錠
剤j)、m(コアが錠剤k)を作成した。[Preparation of Fixing Tablets 1 and m] Subsequently, tablets j and k having a diameter of 21 mm were obtained by using a nucleated rotary tableting machine modified from Clean Press Collect 45DC manufactured by Kikusui Seisakusho Co., Ltd.
Was pressed into a die so that the mixture (KA) obtained in Example 1 became a shell, while being charged into a die so as to become a core. The mixture (KA) was filled so that the weight per tablet was 10 g, and a punch having a diameter of 30 mm was formed using a punch capable of forming a shape having a sugar-coated R surface, as shown in FIGS. 3 (O) and (L). Cylindrical core / shell fixing tablets 1 (core is tablet j) and m (core is tablet k) were prepared.
【0131】〔定着錠剤n、oの作製〕不活性物質とし
てポリエチレングリコール平均分子量4000(PEG
4000)を錠剤1錠当たり0.05gとなるように定
着錠剤j及びkにコーティング機(フロイント産業
(株)製HCT−MINI)にてコーティングしそれぞ
れ定着錠剤n及びoを作成した。[Preparation of fixing tablets n and o] As an inert substance, polyethylene glycol average molecular weight 4000 (PEG
4000) was coated on the fixing tablets j and k with a coating machine (HCT-MINI, manufactured by Freund Corporation) to give 0.05 g per tablet to prepare fixing tablets n and o, respectively.
【0132】〔定着錠剤p、qの作製〕続いて菊水製作
所(株)製クリーンプレスコレクト45DCを改造した
有核回転式打錠機により上記直径21mmのコーティン
グ錠剤n及びoがコアとなるように臼内に投入しながら
実施例1で得られた混合物(KA)がシェルとなるよう
に圧縮打錠を行った。尚、1錠当たり重量が10gにな
るように混合物(KA)を充填し、糖衣R面を有する錠
剤を成形できる杵を使用して直径30mmで図3の
(P)及び(M)に示すような構造の円筒形コア/シェ
ル定着錠剤p(コアが錠剤n)、q(コアが錠剤o)を
作成した。[Preparation of Fixing Tablets p and q] Subsequently, the coated tablets n and o having a diameter of 21 mm were used as cores by using a nucleated rotary tableting machine modified from Clean Press Collect 45DC manufactured by Kikusui Seisakusho Co., Ltd. While being charged into the mortar, compression tableting was performed so that the mixture (KA) obtained in Example 1 became a shell. The mixture (KA) was filled so that the weight per tablet became 10 g, and a punch having a diameter of 30 mm was formed using a punch capable of forming a tablet having a sugar-coated R surface, as shown in FIGS. 3 (P) and (M). Cylindrical core / shell fixing tablets p (core is tablet n) and q (core is tablet o) were prepared.
【0133】〈硬度の評価〉前記操作で得られた錠剤試
料それぞれ20個を硬度測定機(岡田精工社製TS−5
0N)を用いて測定し、その平均値を錠剤試料の硬度
(強度)とした。結果を表2に示す。<Evaluation of Hardness> Twenty tablet samples obtained by the above operation were each measured with a hardness measuring machine (TS-5 manufactured by Okada Seiko Co., Ltd.).
0N), and the average value was taken as the hardness (strength) of the tablet sample. Table 2 shows the results.
【0134】〈錠剤の保存硬度の評価〉更にそれぞれの
錠剤を23℃、湿度40%の雰囲気で図5〜7に示す可
撓性包装体にそれぞれ70個ずつ入れ密封包装して錠剤
の可撓性包装体を作製し、50℃で30日間保存した。
30日後、上記い錠剤可撓性包装体を開封し、上記と同
様な方法で強度を測定した。結果を表2に示す。<Evaluation of Storage Hardness of Tablets> Furthermore, 70 tablets of each tablet were placed in a flexible package shown in FIGS. A flexible package was prepared and stored at 50 ° C. for 30 days.
After 30 days, the tablet flexible package was opened and the strength was measured in the same manner as above. Table 2 shows the results.
【0135】〈溶解性の評価〉更に上記保存条件と全く
同様に保存した錠剤を実施例1と全く同様な方法で溶解
性を評価した。結果を表2に示す。<Evaluation of Solubility> Further, the tablets stored under exactly the same storage conditions as described above were evaluated for solubility in the same manner as in Example 1. Table 2 shows the results.
【0136】[0136]
【表2】 [Table 2]
【0137】表2の如く本発明の錠剤は硬度、保存性に
優れ、かつ溶解速度が速く、保存しても残存物が存在せ
ず完全に溶解することが分かる。As shown in Table 2, the tablet of the present invention is excellent in hardness and preservability, has a high dissolution rate, and completely dissolves without storage even after storage.
【0138】[0138]
【発明の効果】本発明により、硬度、保存性、投入性に
優れ、溶解速度が速く大量に感光材料を迅速処理する自
動現像機に適した感光材料用固体処理剤、感光材料用固
体処理剤の可撓性包装体及び投入方法が得られた。Industrial Applicability According to the present invention, a solid processing agent for a photosensitive material, which is excellent in hardness, storability and injectability, has a high dissolution rate, and is suitable for an automatic developing machine for rapidly processing a large amount of the photosensitive material, Of the flexible package and the charging method.
【図1】本発明の錠剤の一例を示す錠剤中心での断面図
である。FIG. 1 is a cross-sectional view at the center of a tablet showing an example of the tablet of the present invention.
【図2】本発明の錠剤の1例を示す2つ以上の成分構成
に分かれた錠剤の錠剤中心での断面図である。模様の違
いは成分の違いを表す。FIG. 2 is a cross-sectional view of a tablet divided into two or more components at the center of the tablet, showing an example of the tablet of the present invention. Differences in patterns indicate differences in components.
【図3】本発明の錠剤の一例を示すコア/シェル構造を
有する錠剤の錠剤中心での断面図である。FIG. 3 is a cross-sectional view at the center of a tablet having a core / shell structure, showing an example of the tablet of the present invention.
【図4】凸曲面を有していない錠剤の錠剤中心での断面
図である。FIG. 4 is a sectional view of a tablet having no convex curved surface at the center of the tablet.
【図5】本発明の固体処理剤を複数個封入する可橈性包
装体を示す斜視図である。FIG. 5 is a perspective view showing a flexible package enclosing a plurality of solid processing agents of the present invention.
【図6】本発明の固体処理剤を複数個封入する可橈性包
装体の延伸し、折曲部位を有する内装材料及び基板に凸
部を有する内装材の斜視図である。FIG. 6 is a perspective view of an interior material having a stretched and bent portion and an interior material having a projection on a substrate of a flexible package enclosing a plurality of solid processing agents of the present invention.
【図7】本発明の固体処理剤を複数個封入する可橈性包
装体及び開封部位を開封した包装体の斜視図である。FIG. 7 is a perspective view of a flexible package enclosing a plurality of the solid processing agents of the present invention and a package having an opening portion opened.
【図8】本発明の固体処理剤を複数個封入する可橈性包
装体及び包装体中の固体処理剤Jの状態を示す斜視図で
ある。FIG. 8 is a perspective view showing a flexible package in which a plurality of solid processing agents of the present invention are enclosed, and a state of a solid processing agent J in the package.
【図9】自動現像機の処理剤投入部の包装体装填準備状
態を示す斜視図である。FIG. 9 is a perspective view showing a state in which a processing agent charging section of the automatic developing machine is ready for loading a package.
【図10】自動現像機の処理剤投入部に本発明の固体処
理剤を複数個封入する可橈性包装体をセット収容し処理
剤投入直前の状態を示す斜視図である。FIG. 10 is a perspective view showing a state immediately before the processing agent is put in a set of flexible packaging bodies enclosing a plurality of the solid processing agents of the present invention in the processing agent feeding section of the automatic developing machine.
H 球面部の高さ R 球面の半径 r 球面最端部と錠剤の帯部の先端とが接する円の半径
を示す 1 固体処理剤を複数個封入する可橈性包装体 2 内装材 3 基板 4,41,42,43基板より延伸する部位 5 袋状部材(防湿袋) 6 背シール部 7 開封用部位 8 レール状のと凸部 9 自動現像機 10 処理剤投入部 J 錠剤型固体処理剤H Height of the spherical surface part R Radius of the spherical surface r Indicates the radius of the circle where the end of the spherical surface contacts the tip of the tablet band 1 Radial packaging body containing a plurality of solid processing agents 2 Interior material 3 Substrate 4 , 41, 42, 43 A part extending from the substrate 5 A bag-shaped member (moisture-proof bag) 6 A back seal part 7 An opening part 8 A rail-shaped convex part 9 An automatic developing machine 10 A processing agent input part J Tablet type solid processing agent
Claims (9)
って、該複数の面の少なくとも一つの面が凸曲面である
ことを特徴とするハロゲン化銀写真感光材料用固体処理
剤。1. A solid processing agent for a silver halide photographic light-sensitive material, which is a compression-molded tablet having a plurality of surfaces, wherein at least one of the plurality of surfaces is a convex curved surface.
有することを特徴とする請求項1記載のハロゲン化銀写
真感光材料用固体処理剤。 一般式(1) R−(O)xSyOzM 〔式中、Rは置換、無置換の脂肪族基、芳香族基又はヘ
テロ環基を表し、xは0又は1、yは2又は3、zは2
〜8、Mはカチオンを表す。〕2. The solid processing agent for a silver halide photographic light-sensitive material according to claim 1, comprising a compound represented by the following general formula (1). Formula (1) R- (O) x S y O z M [wherein, R is a substituted, represents a non-substituted aliphatic group, an aromatic group or a heterocyclic group, x is 0 or 1, y is 2 Or 3, z is 2
-8 and M represent a cation. ]
成分が少なくとも2つの成分構成に分かれていることを
特徴とするハロゲン化銀写真感光材料用固体処理剤。3. A solid processing agent for a silver halide photographic light-sensitive material, wherein the components in the tablet according to claim 1 or 2 are divided into at least two components.
剤がコア及び少なくとも一層の該コアを被覆するシェル
層を有することを特徴とするハロゲン化銀写真感光材料
用固体処理剤。4. A solid processing agent for a silver halide photographic light-sensitive material, wherein the tablet according to any one of claims 1 to 3 has a core and at least one shell layer covering the core.
つの面が凸曲面である錠剤をコアとし、少なくとも一層
の該コアを被覆するシェル層を有することを特徴とする
請求項4に記載のハロゲン化銀写真感光材料用固体処理
剤。5. The tablet according to claim 4, wherein the core is a tablet having a plurality of surfaces and at least one of the plurality of surfaces is a convex curved surface, and at least one shell layer covering the core. A solid processing agent for a silver halide photographic light-sensitive material as described above.
なくとも一層のチオ硫酸塩を含有する層の間にそれぞれ
の層に不活性な層を設け、圧縮成形したことを特徴とす
るハロゲン化銀写真感光材料用固体処理剤。6. A silver halide photograph wherein an inactive layer is provided between each of a layer containing a water-soluble aluminum salt and at least one layer containing a thiosulfate, and compression-molded. Solid processing agent for photosensitive materials.
コアとし、少なくとも一層のチオ硫酸塩を含有するシェ
ル層を有することを特徴とする請求項1〜6のいずれか
1項に記載のハロゲン化銀写真感光材料用固体処理剤。7. The halogenated compound according to claim 1, wherein a tablet containing a water-soluble aluminum salt is used as a core, and at least one shell layer containing a thiosulfate is provided. Solid processing agent for silver photographic materials.
体処理剤を複数の片を有する包装体に複数個封入したこ
とを特徴とするハロゲン化銀写真感光材料用固体処理剤
の可撓性包装体。8. A solid processing agent for a silver halide photographic light-sensitive material, wherein a plurality of the solid processing agents according to claim 1 are enclosed in a package having a plurality of pieces. Flexible packaging.
性包装体であって、該複数の片の少なくとも1片を開い
て包装体中の複数の錠剤を処理装置内に投入することを
特徴とするハロゲン化銀写真感光材料用固体処理剤の投
入方法。9. The flexible package according to claim 8, comprising a plurality of pieces, wherein at least one of the plurality of pieces is opened and a plurality of tablets in the package are put into the processing device. A method for charging a solid processing agent for a silver halide photographic light-sensitive material, characterized by comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8045797A JPH10274829A (en) | 1997-03-31 | 1997-03-31 | Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8045797A JPH10274829A (en) | 1997-03-31 | 1997-03-31 | Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH10274829A true JPH10274829A (en) | 1998-10-13 |
Family
ID=13718799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8045797A Pending JPH10274829A (en) | 1997-03-31 | 1997-03-31 | Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10274829A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000039272A3 (en) * | 1998-12-24 | 2000-10-26 | Henkel Kgaa | Washing detergent shaped bodies comprising an optimized shape |
| JP2019043635A (en) * | 2017-09-05 | 2019-03-22 | 三井化学株式会社 | Container transportation method |
-
1997
- 1997-03-31 JP JP8045797A patent/JPH10274829A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000039272A3 (en) * | 1998-12-24 | 2000-10-26 | Henkel Kgaa | Washing detergent shaped bodies comprising an optimized shape |
| JP2019043635A (en) * | 2017-09-05 | 2019-03-22 | 三井化学株式会社 | Container transportation method |
| JP2022031973A (en) * | 2017-09-05 | 2022-02-22 | 三井化学株式会社 | A method of repeating the discharge and injection of contents using a container |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10274829A (en) | Solid processing agent for silver halide photographic sensitive material, package of the same and method for putting the same | |
| JP3038414B2 (en) | Photographic processing agents | |
| EP0469877B1 (en) | Packaged photographic solid processing compositions | |
| JPH10312044A (en) | Solid processing agent for silver halide photographic light-sensitive material, package and charging method | |
| JP3030581B2 (en) | Photographic processing agents | |
| EP0789273B1 (en) | Solid developing composition for processing silver halide photographic light-sensitive material | |
| JPH10198006A (en) | Method for processing silver halide photographic sensitive material | |
| JP3450556B2 (en) | Solid processing agent | |
| JP3312189B2 (en) | Processing method of silver halide photographic material | |
| JP2843877B2 (en) | Photographic processing agents | |
| JPH0419739A (en) | Liquid using solid fixer and liquid fixer for silver halide photographic sensitive material | |
| JP2002236340A (en) | Processing method of silver halide photographic light-sensitive material by automatic processor | |
| JPH1020458A (en) | Agent and method for processing silver halide photographic sensitive material | |
| JP3690757B2 (en) | Solid processing agent for silver halide photosensitive materials | |
| JP3245759B2 (en) | Solid processing agent for silver halide color photographic light-sensitive material and processing method using the same | |
| JP2000002974A (en) | Production of solid treating agent for silver halide photographic sensitive material | |
| JPH11242314A (en) | Treatment of silver halide photographic sensitive material | |
| JPH08328207A (en) | Solid fixation processing agent and method for processing silver halide photographic sensitive material | |
| JP2002006452A (en) | Processing method for silver halide photographic sensitive material and processing agent system used in the same | |
| JPH1097034A (en) | Processing agent kit for silver halide photographic sensitive material and method for storing same and processing method by using same | |
| JPH11242312A (en) | Treatment of silver halide photographic sensitive material | |
| JPH08137054A (en) | Solid processing agent for silver halide photographic material | |
| JP2001005150A (en) | Concentrated fixing solution for silver halide photographic sensitive material, solid fixing agent for silver halide photographic sensitive material and processing method for silver halide photographic sensitive material | |
| JPH06266061A (en) | Package for photographic treating agent | |
| JPH09258392A (en) | Processing Part for Silver Halide Photosensitive Materials |